{
    "data": [
        {
            "title": "Table Trac Announces Quarterly Dividend | TBTC Stock News",
            "description": "<article class=\"article\"><p>MINNETONKA, Minn., Feb.  26, 2026  (GLOBE NEWSWIRE) -- On February 26, 2026, the Board of Directors of <b>Table Trac Inc.</b> (the “Company”) (OTCQX: <a class=\"symbol-link\" href=\"/overview/TBTC/\" title=\"View TBTC stock overview\">TBTC</a>) approved a cash dividend on the Company’s common stock of <money>$0.02</money> per share. The dividend is payable on March 27, 2026, to shareholders of record at the close of business on March 13, 2026.</p> <p>“Our ability to continue this quarterly cash distribution reflects the Company’s ongoing commitment to delivering value to our shareholders,” said Randy Gilbert, Chief Executive Officer of the Company. “We are proud to maintain this consistent return of capital while continuing to invest in the long-term growth of the business.”</p> <p><b>About Table Trac, Inc.</b></p> <p>Founded in 1995, Table Trac, Inc. develops, sells and leases information and management systems and provides technical support to casinos. The open architecture of CasinoTrac is designed to provide operators with a secure, scalable, and flexible system that interconnects and operates with most third-party software and hardware. Key products and services include modules that drive player tracking programs, kiosk promotions, and provide vault and cage controls. The Company’s systems are designed to meet strict auditing, accounting and regulatory requirements applicable to the gaming industry.</p> <p>Additionally, the Company has developed a patented, real-time system that automates and monitors the operations of casino gaming tables.</p> <p>The Company’s suite of management systems and kiosks are installed with on-going support and maintenance contracts in over 115 casino operators in over 300 casinos worldwide. The Company continues to increase its market share by expanding its product offerings to include new system features, and ancillary products. More information is available at <a href=\"https://www.globenewswire.com/Tracker?data=BLF7Posl_A1gG35XHYTQmcg868LHcMh8TAzd8Lp5tO7yG8S5hzTE9LWuE9DehqjTxidNkwvIrFwssInZrUjrvtEmlVLac9SITRvEtQb7jrBPkUo-6k6pYHNOWyEw-ZINPdtVZTdrd2DxF7PQHT4elePDs2Jy0wJ_EPVcxqsQEI3p7U3Ztz-rsYRoL8FIQPG2e45K_oa-r01AjhAjpB2EhrDWKvsaUAzGm5m_EN1HxvGYZXzirw-LC3TEkw2ww7OYa4ckytqJiVD05WyjILzLZg==\" rel=\"nofollow noopener\" target=\"_blank\">http://www.tabletrac.com/</a>.</p> <p><b>Forward Looking Statements</b></p> <p>This press release contains forward-looking statements that involve numerous risks and uncertainties. Actual results, performance or achievements could differ materially from those anticipated in such forward-looking statements as a result of certain factors, including those set forth in the Company's filings with the Securities and Exchange Commission.</p> <p><b>For more information:</b><br/>Randy Gilbert                        <br/>Table Trac, Inc.<br/>952-548-8877<b>                </b></p> <img alt=\"\" class=\"__GNW8366DE3E__IMG\" loading=\"lazy\" src=\"https://www.globenewswire.com/newsroom/ti?nf=OTY2MjMxMCM3NDU3ODI1IzIxOTc3MTI=\"/> <br/><img alt=\"\" loading=\"lazy\" referrerpolicy=\"no-referrer-when-downgrade\" src=\"https://ml.globenewswire.com/media/MmFkYjIzNDUtYTgyZC00MTRiLWE4OWUtNTNkY2NlYjQ0OGZmLTEyMDkyNjUtMjAyNi0wMi0yNi1lbg==/tiny/Table-Trac-Inc-.png\"/></article>",
            "link": "https://www.stocktitan.net/news/TBTC/table-trac-announces-quarterly-v71xi9wrmun8.html",
            "author": "stocktitan",
            "pub_date": "Thu, 26 Feb 2026 18:12:00 GMT",
            "source": "stocktitan",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "SBM Offshore starts EUR227 million share repurchase following completion of the 2025 program   | SBFFF Stock News",
            "description": "<article class=\"article\"><p>Amsterdam, February 26, 2026</p> <p align=\"justify\">SBM Offshore announces the completion of its EUR141 million share repurchase program initiated in 2025, and the commencement of a EUR227 million (US<money>$270 million</money> equivalent<sup>1</sup>) share repurchase program, as announced on February 26, 2026, and effective from February 27, 2026.</p> <p align=\"justify\"><b>EUR227 million share repurchase program</b></p> <p align=\"justify\">The objective of the EUR227 million share repurchase program is to reduce share capital and, in addition, to provide shares for regular management and employee share programs (maximum US<money>$30 million</money>). The remainder of the repurchased shares will be cancelled. The share repurchase program is expected to be completed by February 17, 2027 and will be executed under the authorization granted by the Annual General Meeting of the Company on April 9, 2025 and, if granted, the authorization of April 15, 2026.</p> <p align=\"justify\">The share repurchase program will be executed under the terms of an engagement letter with a third party, performed in compliance with the safe harbor provisions for share repurchases, and therefore transactions may be carried out during closed periods.</p> <p align=\"justify\">In accordance with the European Market Abuse Regulation, the Company will inform the market of the progress made in the execution of this program through weekly press releases and updates on its website.</p> <p align=\"justify\"><b>Completion EUR141 million share repurchase program</b></p> <p align=\"justify\">Between April 24, 2025 and February 26, 2026 a total of 6,178,569 shares were repurchased, at an average price of EUR22.85 per share, representing a total of EUR141 million. Information regarding the aggregate of the transactions (calculated on a daily basis) for the period in which the program was executed can be found in the top half of the table below. Further details about individual transactions can be accessed via the Investor Relations section of the Company’s website.</p> <p align=\"justify\">The repurchases were made under the program announced on February 20, 2025 and effective from April 24, 2025.  The objective of the program was to reduce share capital and, in addition, to provide shares for regular management and employee share programs. </p> <p align=\"justify\"><b>Final Period Share Repurchase Program Transaction Details</b></p> <p align=\"justify\">SBM Offshore reports the transaction details related to the repurchases under the program for the last trading day, February 26, 2026, in the bottom half of the table below. </p> <table style=\"border-collapse: collapse; width:484.25pt; border-collapse:collapse ;\"><tr><td colspan=\"3\" style=\"width:312px;;vertical-align: bottom ; \"><b>Share Repurchase Program</b></td><td colspan=\"2\" style=\"width:172.34px;;vertical-align: bottom ; \"><b> </b></td><td colspan=\"2\" style=\"width:161.34px;;vertical-align: bottom ; \"><b> </b></td></tr><tr><td colspan=\"2\" style=\"width:161.34px;;vertical-align: bottom ; \"> </td><td style=\"width:150.67px;;vertical-align: bottom ; \"> </td><td colspan=\"2\" style=\"width:172.34px;;vertical-align: bottom ; \"><b> </b></td><td colspan=\"2\" style=\"width:161.34px;;vertical-align: bottom ; \"><b> </b></td></tr><tr><td colspan=\"4\" style=\"width:407.4px;;vertical-align: bottom ; \"><b>Overall progress Share Repurchase Program:</b></td><td colspan=\"2\" style=\"width:135.8px;;vertical-align: bottom ; \"><b> </b></td><td> </td></tr><tr><td style=\"width:135.8px;;vertical-align: bottom ; \"> </td><td colspan=\"2\" style=\"width:176.2px;;vertical-align: bottom ; \"> </td><td style=\"width:95.4px;;vertical-align: bottom ; \"><b> </b></td><td colspan=\"2\" style=\"width:135.8px;;vertical-align: bottom ; \"><b> </b></td><td> </td></tr><tr><td colspan=\"3\" style=\"width:312px;;vertical-align: bottom ; \">Total Repurchase Amount</td><td style=\"width:95.4px;;vertical-align: bottom ; \"> </td><td colspan=\"2\" style=\"width:135.8px;;text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">EUR 141,189,019</td><td> </td></tr><tr><td colspan=\"3\" style=\"width:312px;;vertical-align: bottom ; \">Cumulative Repurchase Amount</td><td style=\"width:95.4px;;vertical-align: bottom ; \"> </td><td colspan=\"2\" style=\"width:135.8px;;text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">EUR 141,189,058</td><td> </td></tr><tr><td colspan=\"3\" style=\"width:312px;;vertical-align: bottom ; \">Cumulative Quantity Repurchased</td><td style=\"width:95.4px;;vertical-align: bottom ; \"> </td><td colspan=\"2\" style=\"width:135.8px;;text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">6,178,569</td><td> </td></tr><tr><td colspan=\"3\" style=\"width:312px;;vertical-align: bottom ; \">Cumulative Average Repurchase Price</td><td style=\"width:95.4px;;vertical-align: bottom ; \"> </td><td colspan=\"2\" style=\"width:135.8px;;text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">EUR 22.85 </td><td> </td></tr><tr><td style=\"width:135.8px;;vertical-align: bottom ; \">Start Date</td><td colspan=\"2\" style=\"width:176.2px;;vertical-align: bottom ; \"> </td><td style=\"width:95.4px;;vertical-align: bottom ; \"> </td><td colspan=\"2\" style=\"width:135.8px;;text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">April 24, 2025</td><td> </td></tr><tr><td style=\"width:135.8px;;vertical-align: bottom ; \">End Date</td><td colspan=\"2\" style=\"width:176.2px;;vertical-align: bottom ; \"> </td><td style=\"width:95.4px;;vertical-align: bottom ; \"> </td><td colspan=\"2\" style=\"width:135.8px;;text-align: right ;  vertical-align: middle; vertical-align: bottom ; \">February 26, 2026</td><td> </td></tr><tr><td colspan=\"4\" style=\"width:407.4px;;vertical-align: bottom ; \">Percentage of program completed as of February 26, 2026</td><td colspan=\"2\" style=\"width:135.8px;;text-align: right ;  vertical-align: middle; vertical-align: bottom ; \"><percent>100%</percent></td><td> </td></tr><tr><td style=\"width:135.8px;;vertical-align: bottom ; \"> </td><td colspan=\"2\" style=\"width:176.2px;;vertical-align: bottom ; \"> </td><td style=\"width:95.4px;;vertical-align: bottom ; \"> </td><td colspan=\"2\" style=\"width:135.8px;;vertical-align: bottom ; \"> </td><td> </td></tr><tr><td colspan=\"4\" style=\"width:407.4px;;vertical-align: bottom ; \"><b>Overview of details of last trading day:</b></td><td colspan=\"2\" style=\"width:135.8px;;vertical-align: bottom ; \"> </td><td> </td></tr><tr><td style=\"width:135.8px;;vertical-align: bottom ; \"> </td><td colspan=\"2\" style=\"width:176.2px;;vertical-align: bottom ; \"> </td><td style=\"width:95.4px;;vertical-align: bottom ; \"> </td><td colspan=\"2\" style=\"width:135.8px;;vertical-align: bottom ; \"> </td><td> </td></tr><tr><td style=\"width:135.8px;;border-right: solid black 1pt ; border-bottom: solid black 1pt ; vertical-align: middle ; \"><b>Trade Date</b></td><td colspan=\"2\" style=\"width:176.2px;;text-align: right ;  vertical-align: middle; border-right: solid black 1pt ; border-bottom: solid black 1pt ; vertical-align: middle ; \"><b>Quantity Repurchased</b></td><td style=\"width:95.4px;;text-align: right ;  vertical-align: middle; border-right: solid black 1pt ; border-bottom: solid black 1pt ; vertical-align: middle ; \"><b>Average Purchase Price</b></td><td colspan=\"2\" style=\"width:135.8px;;text-align: right ;  vertical-align: middle; border-right: solid black 1pt ; border-bottom: solid black 1pt ; vertical-align: middle ; \"><b>Settlement Amount</b></td><td> </td></tr><tr><td style=\"width:135.8px;;vertical-align: middle ; \">February 26, 2026</td><td colspan=\"2\" style=\"width:176.2px;;text-align: right ;  vertical-align: middle; vertical-align: middle ; \"> 17,234 </td><td style=\"width:95.4px;;text-align: right ;  vertical-align: middle; vertical-align: middle ; \">EUR 32.57</td><td colspan=\"2\" style=\"width:135.8px;;text-align: right ;  vertical-align: middle; vertical-align: middle ; \">EUR 561,396</td><td> </td></tr><tr><td style=\"width:135.8px;;border-top: solid black 1pt ; border-bottom: double black 3pt ; vertical-align: middle ; \"><b>Total</b></td><td colspan=\"2\" style=\"width:176.2px;;text-align: right ;  vertical-align: middle; border-top: solid black 1pt ; border-bottom: double black 3pt ; vertical-align: middle ; \"><b>17,234</b></td><td style=\"width:95.4px;;text-align: right ;  vertical-align: middle; border-top: solid black 1pt ; border-bottom: double black 3pt ; vertical-align: middle ; \"><b>EUR 32.57</b></td><td colspan=\"2\" style=\"width:135.8px;;text-align: right ;  vertical-align: middle; border-top: solid black 1pt ; border-bottom: double black 3pt ; vertical-align: middle ; \"><b>EUR 561,396</b></td><td> </td></tr></table> <p align=\"justify\"><i>All shares purchased via Euronext Amsterdam, CBOE DXE and or Turquoise</i></p> <p align=\"justify\">This press release contains information which is to be made publicly available under the Market Abuse Regulation (nr. 596/2014). The information concerns a regular update of the transactions conducted under SBM Offshore’s share repurchase program, as announced by the Company on February 26, 2026, details of which are available on its website.</p> <p><br/><b>Corporate Profile</b></p> <p align=\"justify\">SBM Offshore is a global leader in deepwater ocean infrastructure, delivering floating production solutions across the full asset lifecycle—from design and construction to installation and operation. Supported by a global team of more than 8,000 professionals, the Company operates a long-term, asset-backed business model that delivers high-availability assets and predictable cash flows. SBM Offshore combines engineering expertise, operational reliability, and selective innovation to support safe, efficient, and lower-carbon energy production, while extending its capabilities into new opportunities across the blue economy.</p> <p align=\"justify\">For further information, please visit our website at <a href=\"https://www.globenewswire.com/Tracker?data=RbD21UvxizlPIu0x1cK-CB4oYeTYf3B1Lsb2oLFk80U4V5ZQtdnIeo8jiEYrETb21L3vf5ntePBo9reTORD9ND0skAIIzMPe-8Lc1IZNkXo=\" rel=\"nofollow noopener\" target=\"_blank\">www.sbmoffshore.com</a>.</p> <table style=\"border-collapse: collapse; width:501.35pt; border-collapse:collapse ;\"><tr><td style=\"width:405.2px;;text-align: justify ;  vertical-align: middle; border-bottom: solid black 1pt ; vertical-align: middle ; \"><b>Financial Calendar </b></td><td style=\"width:29.6px;;border-bottom: solid black 1pt ; vertical-align: middle ; \"><b> </b></td><td style=\"width:153.8px;;text-align: right ;  vertical-align: middle; border-bottom: solid black 1pt ; vertical-align: middle ; \"><b>Date</b></td><td style=\"width:79.87px;;text-align: right ;  vertical-align: middle; border-bottom: solid black 1pt ; vertical-align: middle ; \"><b>Year</b></td></tr><tr><td style=\"width:405.2px;;vertical-align: middle ; \">Annual General Meeting</td><td style=\"width:29.6px;;vertical-align: middle ; \"> </td><td style=\"width:153.8px;;text-align: right ;  vertical-align: middle; vertical-align: middle ; \">April 15</td><td style=\"width:79.87px;;text-align: right ;  vertical-align: middle; vertical-align: middle ; \">2026</td></tr><tr><td style=\"width:405.2px;;vertical-align: middle ; \">First Quarter 2026 Trading Update</td><td style=\"width:29.6px;;vertical-align: middle ; \"> </td><td style=\"width:153.8px;;text-align: right ;  vertical-align: middle; vertical-align: middle ; \">May 7</td><td style=\"width:79.87px;;text-align: right ;  vertical-align: middle; vertical-align: middle ; \">2026</td></tr><tr><td style=\"width:405.2px;;vertical-align: middle ; \">Half Year 2026 Earnings</td><td style=\"width:29.6px;;vertical-align: middle ; \"> </td><td style=\"width:153.8px;;text-align: right ;  vertical-align: middle; vertical-align: middle ; \">August 6</td><td style=\"width:79.87px;;text-align: right ;  vertical-align: middle; vertical-align: middle ; \">2026</td></tr><tr><td style=\"width:405.2px;;vertical-align: middle ; \">Third Quarter 2026 Trading Update</td><td style=\"width:29.6px;;vertical-align: middle ; \"> </td><td style=\"width:153.8px;;text-align: right ;  vertical-align: middle; vertical-align: middle ; \">November 12</td><td style=\"width:79.87px;;text-align: right ;  vertical-align: middle; vertical-align: middle ; \">2026</td></tr><tr><td style=\"width:405.2px;;vertical-align: middle ; \">Full Year 2026 Earnings</td><td style=\"width:29.6px;;vertical-align: middle ; \"> </td><td style=\"width:153.8px;;text-align: right ;  vertical-align: middle; vertical-align: middle ; \">February 18</td><td style=\"width:79.87px;;text-align: right ;  vertical-align: middle; vertical-align: middle ; \">2027</td></tr></table> <p align=\"justify\">For further information, please contact:</p> <p><b>Investor Relations</b></p> <p align=\"justify\">Wouter Holties<br/>Corporate Finance &amp; Investor Relations Manager</p> <table style=\"border-collapse: collapse; border-collapse:collapse ;\"><tr><td style=\"width:89.67px;;text-align: justify ;  vertical-align: middle; vertical-align: top ; \">Phone:</td><td style=\"width:234px;;text-align: justify ;  vertical-align: middle; vertical-align: top ; \">+31 (0)20 236 32 36</td></tr><tr><td style=\"width:89.67px;;text-align: justify ;  vertical-align: middle; vertical-align: top ; \">E-mail:</td><td style=\"width:234px;;text-align: justify ;  vertical-align: middle; vertical-align: top ; \"><a href=\"mailto:wouter.holties@sbmoffshore.com\" rel=\"nofollow noopener\" target=\"_blank\">wouter.holties@sbmoffshore.com</a></td></tr><tr><td style=\"width:89.67px;;text-align: justify ;  vertical-align: middle; vertical-align: top ; \">Website:</td><td style=\"width:234px;;text-align: justify ;  vertical-align: middle; vertical-align: top ; \"><a href=\"http://www.sbmoffshore.com\" rel=\"nofollow noopener\" target=\"_blank\">www.sbmoffshore.com</a></td></tr></table> <p><b>Media Relations</b></p> <p align=\"justify\">Giampaolo Arghittu<br/>Head of External Relations</p> <table style=\"border-collapse: collapse; border-collapse:collapse ;\"><tr><td style=\"width:89.67px;;text-align: justify ;  vertical-align: middle; vertical-align: top ; \">Phone:</td><td style=\"width:240.34px;;text-align: justify ;  vertical-align: middle; vertical-align: top ; \">+31 (0)6 212 62 333 / +39 33 494 79 584</td></tr><tr><td style=\"width:89.67px;;text-align: justify ;  vertical-align: middle; vertical-align: top ; \">E-mail:</td><td style=\"width:240.34px;;text-align: justify ;  vertical-align: middle; vertical-align: top ; \"><a href=\"mailto:giampaolo.arghittu@sbmoffshore.com\" rel=\"nofollow noopener\" target=\"_blank\">giampaolo.arghittu@sbmoffshore.com</a></td></tr><tr><td style=\"width:89.67px;;text-align: justify ;  vertical-align: middle; vertical-align: top ; \">Website:</td><td style=\"width:240.34px;;text-align: justify ;  vertical-align: middle; vertical-align: top ; \"><a href=\"http://www.sbmoffshore.com\" rel=\"nofollow noopener\" target=\"_blank\">www.sbmoffshore.com</a></td></tr></table> <p align=\"justify\"><u>Market Abuse Regulation</u></p> <p align=\"justify\">This press release may contain inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation.</p> <p align=\"justify\"><u>Disclaimer</u></p> <p align=\"justify\">Some of the statements contained in this release that are not historical facts are statements of future expectations and other forward-looking statements based on management’s current views, expectations and various assumptions regarding the financial and non-financial position of SBM Offshore N.V., anticipated developments and other factors, and involve known and unknown risks, dependencies and uncertainties that could cause actual results, performance, or events to differ materially from those in such statements. These statements may be identified by words such as ‘expect’, ‘should’, ‘could’, ‘shall’ and / or similar expressions. Such forward-looking statements are subject to various risks and uncertainties. The principal risks which could affect the future operations of SBM Offshore N.V. are described in the ‘Impacts, Risks and Opportunities’ section of the 2025 Annual Report.</p> <p align=\"justify\">Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results and performance of the Company’s business may vary materially and adversely from the forward-looking statements described in this release. SBM Offshore N.V. does not intend and does not assume any obligation to update any industry information or forward-looking statements set forth in this release to reflect new information, subsequent events or otherwise. </p> <p align=\"justify\">Data underpinning certain disclosures – particularly sustainability-related - may be subject to inherent limitations. These limitations include but are not limited to reliance on third party data providers whose data quality, completeness and integrity may differ; the use of estimates and assumptions where actual data is unavailable or incomplete; and dependencies on value chain partners for timely and accurate information provision. Methodologies, standards and regulatory requirements for measuring and reporting information—especially sustainability related information—continue to evolve. As a result, our measurement approaches and reported figures may be refined over time as more accurate, granular or standardized data becomes available. Accordingly, all data, and emissions data in particular, should be interpreted in light of these limitations and the ongoing maturation of sustainability reporting practices across our value chain.</p> <p align=\"justify\">This release contains certain alternative performance measures (APMs) as defined by the ESMA guidelines which are not defined under IFRS. Further information on these APMs is included in 2025 Annual Report, available on our website <a href=\"https://www.globenewswire.com/Tracker?data=KwCOtiJ2jKmT9EE8CDWKsVlF0hhH36bQpU6n7UWTlNnQVuFX7GLA_IfwXLspn6pbO18TfmWNDc3aX7lbVkHoDumWjxLH8eP4dQ0pO5JsfQ9l49TtTyH8N3hOym0Fn7gZbRjvCNzGcmy33UBpDpDVKw==\" rel=\"nofollow noopener\" target=\"_blank\">Annual Reports - SBM Offshore</a>.</p> <p align=\"justify\">Nothing in this release shall be deemed an offer to sell, or a solicitation of an offer to buy, any securities. The companies in which SBM Offshore N.V. directly and indirectly owns investments are separate legal entities. In this release “SBM Offshore” and “SBM” are sometimes used for convenience where references are made to SBM Offshore N.V. and its subsidiaries in general. These expressions are also used where no useful purpose is served by identifying the particular company or companies.</p> <p align=\"justify\">\"SBM Offshore<sup>®</sup>\", the SBM logomark, “Fast4Ward<sup>®</sup>”, and “F4W<sup>®</sup>” and “Imodco<sup>®</sup>” are proprietary marks owned by SBM Offshore.</p> <hr/> <p><sup>1</sup> Based on the EUR/US$ forward exchange rate on February 18, 2026.</p> <p id=\"gnw_attachments_section-header\"><strong>Attachment</strong></p><ul id=\"gnw_attachments_section-items\"><li><a href=\"https://ml-eu.globenewswire.com/Resource/Download/85ccba47-39d5-488e-970d-b0753dc06d4e\" rel=\"nofollow noopener\" target=\"_blank\">SBM Offshore starts EUR227 million share repurchase following completion of the 2025 program</a></li></ul><img alt=\"\" class=\"__GNW8366DE3E__IMG\" loading=\"lazy\" src=\"https://www.globenewswire.com/newsroom/ti?nf=MTAwMTE2NzA3OCM0MDIzNDk1MzIjMjAwMTEyNw==\"/> <br/><img alt=\"\" loading=\"lazy\" referrerpolicy=\"no-referrer-when-downgrade\" src=\"https://ml-eu.globenewswire.com/media/ZjY5ZWVkZWUtZjRhZi00OWNlLWJkMTItNjdkMjYxYmI0MTc5LTEwMTI3MDAtMjAyNi0wMi0yNi1lbg==/tiny/SBM-Offshore-Amsterdam-B-V-.png\"/></article>",
            "link": "https://www.stocktitan.net/news/SBFFF/sbm-offshore-starts-eur227-million-share-repurchase-following-n6k65c2qqm3c.html",
            "author": "stocktitan",
            "pub_date": "Thu, 26 Feb 2026 18:20:00 GMT",
            "source": "stocktitan",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Starwood Property Trust Announces Authorization of $400 Million Share Repurchase Program | STWD Stock News",
            "description": "<article class=\"article\"><div class=\"xn-content\"><p><span class=\"legendSpanClass\"><location idsrc=\"xmltag.org\" value=\"LU/us.fl.mibch\">MIAMI BEACH, Fla.</location></span>, <span class=\"legendSpanClass\">Feb. 26, 2026</span> /PRNewswire/ -- Starwood Property Trust, Inc. (NYSE: <a class=\"symbol-link\" href=\"/overview/STWD/\" title=\"View STWD stock overview\">STWD</a>) today announced that its Board of Directors has authorized the repurchase of up to <money><money>$400 million</money></money> of its outstanding shares of common stock and convertible notes over a period of one year.  The share repurchase program will be funded through the Company's existing cash.</p><p>Purchases made pursuant to the program will be made either in the open market or in privately negotiated transactions from time to time as permitted by federal securities laws and other legal requirements. The timing, manner, price and amount of any repurchases will be determined by the Company in its discretion and will be subject to economic and market conditions, stock price, applicable legal requirements and other factors. The program may be suspended or discontinued at any time.</p><p><u>About Starwood Property Trust, Inc.</u></p><p>Starwood Property Trust (NYSE: <a class=\"symbol-link\" href=\"/overview/STWD/\" title=\"View STWD stock overview\">STWD</a>), an affiliate of global private investment firm Starwood Capital Group, is a leading diversified finance company with a core focus on the real estate and infrastructure sectors. As of December 31, 2025, the Company has successfully deployed <money><money>$115 billion</money></money> of capital since inception and manages a portfolio of over <money><money>$30 billion</money></money> across debt and equity investments. Starwood Property Trust's investment objective is to generate attractive and stable returns for shareholders, primarily through dividends, by leveraging a premiere global organization to identify and execute on the best risk adjusted returning investments across its target assets. Additional information can be found at <u><a href=\"https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4628443-1&amp;h=4216563761&amp;u=https%3A%2F%2Fwww.starwoodpropertytrust.com%2F&amp;a=www.starwoodpropertytrust.com\" rel=\"nofollow noopener\" target=\"_blank\">www.starwoodpropertytrust.com</a></u>. </p><p>Forward-Looking Statements</p><p>Statements in this press release which are not historical fact may be deemed forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.  Forward-looking statements are developed by combining currently available information with our beliefs and assumptions and are generally identified by the words \"believe,\" \"expect,\" \"anticipate\" and other similar expressions. Although Starwood Property Trust, Inc. believes the expectations reflected in any forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be attained.  Factors that could cause actual results to differ materially from the Company's expectations include, but are not limited to, completion of pending investments and financings, continued ability to acquire additional investments, competition within the finance and real estate industries, availability of financing, and other risks detailed under the heading \"Risk Factors\" in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2025, as well as other risks and uncertainties set forth from time to time in the Company's reports filed with the SEC.</p><p>In light of these risks and uncertainties, there can be no assurances that the results referred to in the forward-looking statements contained herein will in fact occur. Except to the extent required by applicable law or regulation, we undertake no obligation to, and expressly disclaim any such obligation to, update or revise any forward-looking statements to reflect changed assumptions, the occurrence of anticipated or unanticipated events, changes to future results over time or otherwise.</p><p>Additional information can be found on the Company's website at <u><a href=\"http://www.starwoodpropertytrust.com\" rel=\"nofollow noopener\">www.starwoodpropertytrust.com</a></u>.</p><p>Contact:<br/>Zachary Tanenbaum<br/>Starwood Property Trust<br/>Phone: 203-422-7788<br/>Email: <a href=\"mailto:ztanenbaum@starwood.com\" rel=\"nofollow noopener\" target=\"_blank\">ztanenbaum@starwood.com</a></p><p>SOURCE Starwood Property Trust, Inc.</p></div></article>",
            "link": "https://www.stocktitan.net/news/STWD/starwood-property-trust-announces-authorization-of-400-million-share-0wf1vevh5q7a.html",
            "author": "stocktitan",
            "pub_date": "Thu, 26 Feb 2026 20:16:00 GMT",
            "source": "stocktitan",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "CPKC announces filing of 2025 annual report on Form 10-K | CP Stock News",
            "description": "<article class=\"article\"><div class=\"xn-content\"><p><span class=\"legendSpanClass\"><location idsrc=\"xmltag.org\" value=\"LU/ca.ab.calgry\">CALGARY, AB</location></span>, <span class=\"legendSpanClass\">Feb. 26, 2026</span> /PRNewswire/ - Canadian Pacific Kansas City (TSX: <a class=\"symbol-link\" href=\"/overview/CP/\" title=\"View CP stock overview\">CP</a>) (NYSE: <a class=\"symbol-link\" href=\"/overview/CP/\" title=\"View CP stock overview\">CP</a>) (CPKC) said today that it has completed the filing of its 2025 annual report on Form 10-K, including the annual audited financial statements and management's discussion and analysis, with the <location idsrc=\"xmltag.org\" value=\"LC/us\">U.S.</location> Securities and Exchange Commission and Canadian securities regulators. A copy of CPKC's 2025 Annual Report is available at <a href=\"https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4626709-1&amp;h=3275282072&amp;u=https%3A%2F%2Finvestor.cpkcr.com%2F&amp;a=https%3A%2F%2Finvestor.cpkcr.com%2F\" rel=\"nofollow noopener\" target=\"_blank\">https://investor.cpkcr.com/</a></p><div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\"><p><a href=\"https://mma.prnewswire.com/media/2919787/CPKC_CPKC_announces_filing_of_2025_annual_report_on_Form_10_K.html\" rel=\"nofollow noopener\" target=\"_blank\"><img alt=\"CPKC Logo (CNW Group/CPKC)\" loading=\"lazy\" src=\"https://mma.prnewswire.com/media/2919787/CPKC_CPKC_announces_filing_of_2025_annual_report_on_Form_10_K.jpg\" title=\"CPKC Logo (CNW Group/CPKC)\"/></a></p></div><p>Shareholders may request a printed copy of the complete 2025 audited financial statements, free of charge, by email to <a href=\"mailto:shareholder@cpkcr.com\" rel=\"nofollow noopener\" target=\"_blank\">shareholder@cpkcr.com</a> or by regular mail to Shareholder Services, Canadian Pacific Kansas City, 7550 Ogden Dale Road S.E., <location idsrc=\"xmltag.org\" value=\"LU/ca.ab.calgry\">Calgary, Alberta</location>, T2C 4X9.</p><p><b>About CPKC</b></p><p>With its global headquarters in <location idsrc=\"xmltag.org\" value=\"LU/ca.ab.calgry\">Calgary, Alta.</location>, <location idsrc=\"xmltag.org\" value=\"LC/ca\">Canada</location>, CPKC is the first and only single-line transnational railway linking <location idsrc=\"xmltag.org\" value=\"LC/ca\">Canada</location>, <location idsrc=\"xmltag.org\" value=\"LC/us\">the United States</location> and México, with unrivaled access to major ports from <location idsrc=\"xmltag.org\" value=\"LU/ca.bc.vancvr\">Vancouver</location> to <location idsrc=\"xmltag.org\" value=\"LC/ca\">Atlantic Canada</location> to the Gulf Coast to Lázaro Cárdenas, México. Stretching approximately 20,000 route miles and employing 20,000 railroaders, CPKC provides North American customers unparalleled rail service and network reach to key markets across the continent. CPKC is growing with its customers, offering a suite of freight transportation services, logistics solutions and supply chain expertise. Visit <a href=\"https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4626709-1&amp;h=148604719&amp;u=https%3A%2F%2Fwww.cpkcr.com%2Fen&amp;a=cpkcr.com\" rel=\"nofollow noopener\" target=\"_blank\">cpkcr.com</a> to learn more about the rail advantages of CPKC. CP-IR</p><p><b><span>Contacts:<br/></span></b><b><span>Media<br/></span></b><a href=\"mailto:mediarelations@cpkcr.com\" rel=\"nofollow noopener\" target=\"_blank\"><span>mediarelations@cpkcr.com</span></a><span>  </span></p><p><b><span>Investment Community<br/></span></b><span>Chris De Bruyn<br/></span><span>403-319-3591<br/></span><a href=\"mailto:investor@cpkcr.com\" rel=\"nofollow noopener\" target=\"_blank\"><span>investor@cpkcr.com</span></a></p><p>SOURCE CPKC</p></div></article>",
            "link": "https://www.stocktitan.net/news/CP/cpkc-announces-filing-of-2025-annual-report-on-form-10-zvfahrakzjbj.html",
            "author": "stocktitan",
            "pub_date": "Thu, 26 Feb 2026 18:15:00 GMT",
            "source": "stocktitan",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "CSX Corporation Announces Increase to Quarterly Dividend | CSX Stock News",
            "description": "<article class=\"article\"><p align=\"left\">JACKSONVILLE, Fla., Feb.  26, 2026  (GLOBE NEWSWIRE) -- <a class=\"symbol-link\" href=\"/overview/CSX/\" title=\"View CSX stock overview\">CSX</a> Corp. (NASDAQ: <a class=\"symbol-link\" href=\"/overview/CSX/\" title=\"View CSX stock overview\">CSX</a>) announced today that the Company’s Board of Directors approved a <money>$0.14</money> per share quarterly dividend on the Company’s common stock, payable on March 13, 2026, to shareholders of record at the close of business on February 27, 2026. This reflects an eight percent increase over the previous dividend payment of <money>$0.13</money> per share.</p> <p align=\"left\"><strong>About <a class=\"symbol-link\" href=\"/overview/CSX/\" title=\"View CSX stock overview\">CSX</a> and its Disclosures</strong></p> <p align=\"left\">CSX, based in Jacksonville, Florida, is a premier transportation company. It provides rail, intermodal and rail-to-truck transload services and solutions to customers across a broad array of markets, including energy, industrial, construction, agricultural, and consumer products. For nearly 200 years, CSX has played a critical role in the nation's economic expansion and industrial development. Its network connects every major metropolitan area in the eastern United States, where nearly two-thirds of the nation's population resides. It also links more than 240 short-line railroads and more than 70 ocean, river and lake ports with major population centers and farming towns alike.   </p> <p align=\"left\">This announcement, as well as additional financial information, is available on the Company's website at <a href=\"https://www.globenewswire.com/Tracker?data=eVJOJD1YiOSeMLu9qZJe2S6DJFLyCQO1jOrwvJ0pE7uRKZzEFoPjAzgrCFGVERxGS1k27_S1rp-y5bxf9v4NsLycz3pdOzM6iG83vXc_YmM=\" rel=\"nofollow noopener\" target=\"_blank\">investors.csx.com</a>. CSX also uses social media channels to communicate information about the company. Although social media channels are not intended to be the primary method of disclosure for material information, it is possible that certain information CSX posts on social media could be deemed to be material. Therefore, we encourage investors, the media, and others interested in the company to review the information we post on <a href=\"https://www.globenewswire.com/Tracker?data=w9KWc6VHvhVFN5iV5RGdFfNiz1L6NBzQuw8DRfL7LOgluGaWCy0uL-qtr1cpTy36TME-TxS9VkTiWVX2g8guA0RxdJOxpdXbPAoqZ_luakc=\" rel=\"nofollow noopener\" target=\"_blank\">Facebook</a> and on <a href=\"https://www.globenewswire.com/Tracker?data=pwLJg6gqOj2O9ZjLswn9DxNkV4eztKdGlR8GUMeYji5-oM85fPGhidUqPswoPZ9MrpzTWDvcuQ3jJgRknk_nrw==\" rel=\"nofollow noopener\" target=\"_blank\">X</a>, formerly known as Twitter. The social media channels used by CSX may be updated from time to time.  More information about CSX Corporation and its subsidiaries is available at <a href=\"https://www.globenewswire.com/Tracker?data=uoRu4KsdKX4B6AFyyucFaGpyQpd4JXOEBSK6rZgLjQl0y3PJA8NqSctdEgOvfFRPxDWW-A8y0PqqUC0I3dAN0w==\" rel=\"nofollow noopener\" target=\"_blank\">www.csx.com</a>.<br/><br/><strong>Contact</strong>:<br/>Matthew Korn, CFA, Investor Relations and Corporate Communications<br/>904-366-4515</p> <img alt=\"\" class=\"__GNW8366DE3E__IMG\" loading=\"lazy\" src=\"https://www.globenewswire.com/newsroom/ti?nf=OTY2MjMzOCM3NDU3ODU0IzIwMDU0MzA=\"/> <br/><img alt=\"\" loading=\"lazy\" referrerpolicy=\"no-referrer-when-downgrade\" src=\"https://ml.globenewswire.com/media/ODMyNTU0OTktZmQ4OS00ZTBjLWFhZTUtZTZkMzhiY2Y2M2NiLTEwMTcwMDMtMjAyNi0wMi0yNi1lbg==/tiny/CSX-Corporation.png\"/></article>",
            "link": "https://www.stocktitan.net/news/CSX/csx-corporation-announces-increase-to-quarterly-mvgv4u7lk3br.html",
            "author": "stocktitan",
            "pub_date": "Thu, 26 Feb 2026 19:00:00 GMT",
            "source": "stocktitan",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "FirstEnergy Enhances Leadership Team with Appointment of Hannah Turner as Vice President, Transmission Finance | FE Stock News",
            "description": "<article class=\"article\"><div class=\"xn-content\"><p class=\"prntac\"><b><i>Industry veteran to guide financial strategy for FirstEnergy Transmission</i></b></p><p><span class=\"legendSpanClass\"><location idsrc=\"xmltag.org\" value=\"LU/us.oh.akron\">AKRON, Ohio</location></span>, <span class=\"legendSpanClass\">Feb. 26, 2026</span> /PRNewswire/ -- FirstEnergy Corp. (NYSE: <a class=\"symbol-link\" href=\"/overview/FE/\" title=\"View FE stock overview\">FE</a>) has named Hannah Turner as Vice President, Transmission Finance, where she will oversee financial operations and regulatory support for FirstEnergy Transmission LLC (FET), Keystone Appalachian Transmission Company (KATCo) and the company's integrated transmission businesses. She has also been named Principal Financial Officer for FirstEnergy Transmission effective March 1, 2026.</p><div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\"><p><a href=\"https://mma.prnewswire.com/media/2921612/Hannah_Turner.html\" rel=\"nofollow noopener\" target=\"_blank\"><img alt=\"Hannah Turner has been named Vice President, FirstEnergy Transmission Finance, where she will oversee financial operations and regulatory support for FirstEnergy Transmission LLC (FET), Keystone Appalachian Transmission Company (KATCo) and the company’s integrated transmission businesses. She has also been named Principal Financial Officer for FirstEnergy Transmission effective March 1, 2026.\" loading=\"lazy\" src=\"https://mma.prnewswire.com/media/2921612/Hannah_Turner.jpg\" title=\"Hannah Turner has been named Vice President, FirstEnergy Transmission Finance, where she will oversee financial operations and regulatory support for FirstEnergy Transmission LLC (FET), Keystone Appalachian Transmission Company (KATCo) and the company’s integrated transmission businesses. She has also been named Principal Financial Officer for FirstEnergy Transmission effective March 1, 2026.\"/></a></p></div><p>She joins FirstEnergy at a pivotal time as the company advances the multiyear Valley Link Transmission joint venture with Dominion Energy and Transource Energy, launches the new Grid Growth Ventures joint venture with Transource Energy and pursues additional efforts to strengthen the regional power grid.</p><p>In this role, Turner will direct financial planning and reporting for transmission operations, serve as the primary financial liaison to the FET board and investors, oversee the Transmission rates team and manage regulatory filings. She will also work with internal and external partners to address strategic, financial and operational risks and support continuous improvement.</p><p>Turner brings deep joint venture and leadership experience from Electric Transmission Texas (ETT), where she most recently served as President, leading a multibillion-dollar enterprise, strengthening governance and advancing system resiliency initiatives. Previously, she served as ETT's Vice President of Finance and Regulatory, directing financial planning, analysis and compliance programs that improved performance and streamlined reporting.</p><p>Earlier in her career at American Electric Power, she helped align financial structures and regulatory strategies across multiple joint ventures – experience that support's FirstEnergy's focus on regional collaboration and long-range planning.</p><p>\"Hannah's experience leading major transmission organizations and navigating complex regulatory environments will be a tremendous asset to our leadership team. Her strategic and collaborative approach will strengthen our financial foundation and support continued growth. I'm confident she will quickly make a positive impact for our customers and stakeholders,\" said Mark Mroczynski, President of Transmission at FirstEnergy.</p><p>Turner holds both a Master of Business Administration and a Bachelor of Business Administration from LeTourneau University.</p><p><b><i>A professional photo of Turner is available for download on <a href=\"https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4628633-1&amp;h=1974567946&amp;u=https%3A%2F%2Fflic.kr%2Fs%2FaHsjE3t2up&amp;a=Flickr\" rel=\"nofollow noopener\" target=\"_blank\">Flickr</a>.</i></b></p><p><b>About FirstEnergy Transmission<br/></b>FirstEnergy Transmission, jointly owned by FirstEnergy Corp. and Brookfield Super-Core Infrastructure Partners, owns and operates American Transmission Systems Inc. (ATSI), Mid-Atlantic Interstate Transmission LLC (MAIT) and Trans-Allegheny Interstate Line Company (TrAILCo). FirstEnergy is one of the nation's largest investor-owned electric systems, serving more than six million customers in <location idsrc=\"xmltag.org\" value=\"LS/us.oh\">Ohio</location>, <location idsrc=\"xmltag.org\" value=\"LS/us.pa\">Pennsylvania</location>, <location idsrc=\"xmltag.org\" value=\"LS/us.nj\">New Jersey</location>, <location idsrc=\"xmltag.org\" value=\"LS/us.wv\">West Virginia</location>, <location idsrc=\"xmltag.org\" value=\"LS/us.md\">Maryland</location> and <location idsrc=\"xmltag.org\" value=\"LU/us.ny.nyc\">New York</location>. The company's transmission subsidiaries operate approximately 24,000 miles of transmission lines that connect the Midwest and Mid-Atlantic regions. Follow FirstEnergy online at <a href=\"https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4628633-1&amp;h=1248909584&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4271990-1%26h%3D2427636352%26u%3Dhttp%253A%252F%252Fwww.firstenergycorp.com%252F%26a%3Dfirstenergycorp.com&amp;a=firstenergycorp.com\" rel=\"nofollow noopener\" target=\"_blank\">firstenergycorp.com</a> and on X <a href=\"https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4628633-1&amp;h=2832750126&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4271990-1%26h%3D2394511167%26u%3Dhttps%253A%252F%252Fx.com%252Ffirstenergycorp%26a%3D%2540FirstEnergyCorp&amp;a=%40FirstEnergyCorp\" rel=\"nofollow noopener\" target=\"_blank\">@FirstEnergyCorp</a>.</p><p> </p><p>SOURCE FirstEnergy Corp.</p></div></article>",
            "link": "https://www.stocktitan.net/news/FE/first-energy-enhances-leadership-team-with-appointment-of-hannah-3d8msu6dyvpz.html",
            "author": "stocktitan",
            "pub_date": "Thu, 26 Feb 2026 20:07:00 GMT",
            "source": "stocktitan",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "New Era Energy & Digital Strengthens Integrated Power Positioning at TCDC with Strategic 54-Acre Corridor LOI | NUAI Stock News",
            "description": "<article class=\"article\"><p> <location idsrc=\"xmltag.org\" value=\"LU/us.tx.midand\">MIDLAND, Texas</location>--(BUSINESS WIRE)--New Era Energy &amp; Digital, Inc. (Nasdaq: <a class=\"symbol-link\" href=\"/overview/NUAI/\" title=\"View NUAI stock overview\">NUAI</a>) (“New Era” or the “Company”), a developer and operator of next-generation digital infrastructure and integrated power assets in the Permian Basin, today announced it has entered into a non-binding Letter of Intent (\"LOI\") to acquire approximately 54 acres of strategically located land adjacent to its Texas Critical Data Centers (“TCDC”) campus in <location idsrc=\"xmltag.org\" value=\"LU/us.tx.ector\">Ector County, Texas</location>.</p><div id=\"bwbodyimg\" style=\"width: 150px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;\"><img alt=\"Site Overview\" loading=\"lazy\" src=\"https://mms.businesswire.com/media/20260226055146/en/2732622/4/New_Era.jpg\"/><p style=\"font-size:85%;\">Site Overview</p></div><p>The contemplated acquisition was undertaken as part of ongoing lease negotiations with a leading hyperscale tenant and partners, where securing the additional acreage emerged as a key milestone in advancing discussions. This development is accompanied by continued site advancement, including initial land clearing, removal of out-of-service and abandoned pipeline infrastructure, relocation of active lines, and subsurface soil sampling to support civil engineering design. These activities are intended to optimize the developable footprint and maximize usable acreage for data center deployment.</p><p>By seeking to consolidate this corridor, New Era is looking to enhance its ability to structure direct power solutions and optimize interconnection design as it advances development of its now 438-acre, master-planned TCDC campus, which is designed to scale to more than 1 gigawatt over time.</p><p>The additional acreage would expand New Era’s capacity to:</p><ul class=\"bwlistdisc\"><li>Directly on next for major power offtake arrangements with nearby energy generation and transport infrastructure</li><li>Negotiate more efficient and flexible interconnection structures</li><li>Reduce exposure to broader grid congestion and transmission constraints; and</li><li>Enhance redundancy, reliability, and long-term expansion flexibility</li></ul><p>The Company expects control of the corridor between operating generation assets and its campus footprint may potentially increase New Era’s negotiating leverage with power producers while improving development sequencing. It also expands the Company’s options for transmission access and energy integration, which are critical for hyperscale and high-performance computing tenants requiring scalable, resilient power infrastructure.</p><p>E. Will Gray II, CEO of New Era Energy &amp; Digital commented: “By taking the first step to secure this additional 54 acres, we are seeking to strengthen our strategic land position between major power generation and transmission assets and take a pivotal step toward finalizing a definitive lease agreement with our end tenant. This transaction would further reinforce TCDC’s positioning as an integrated power and digital infrastructure platform designed for long-term expansion and operational reliability.”</p><p><b>About New Era Energy &amp; Digital, Inc.<br/></b>New Era Energy &amp; Digital, Inc. (Nasdaq: <a class=\"symbol-link\" href=\"/overview/NUAI/\" title=\"View NUAI stock overview\">NUAI</a>) is a developer and operator of next-generation digital infrastructure and integrated power assets. The Company is developing Texas Critical Data Centers LLC (“TCDC”), a 438 acre large-scale AI and high-performance computing data center campus located in <location idsrc=\"xmltag.org\" value=\"LU/us.tx.ector\">Ector County</location>, outside <location idsrc=\"xmltag.org\" value=\"LU/us.tx.odessa\">Odessa, Texas</location>. TCDC is master-planned as a multi-phase development, with anticipated capacity scaling to 1+ gigawatt over time. With a growing portfolio of strategically located, vertically integrated resources including powered land and powered shells, the Company delivers turnkey solutions that enable hyperscale, enterprise, and edge operators to accelerate data center deployment, optimize total cost of ownership, and future-proof their infrastructure investments. For more information, visit: <a href=\"https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.newerainfra.ai&amp;esheet=54434772&amp;newsitemid=20260226055146&amp;lan=en-US&amp;anchor=www.newerainfra.ai&amp;index=1&amp;md5=891a64b601b355ae1a0d42ba10ccb9a2\" rel=\"nofollow noopener\" shape=\"rect\">www.newerainfra.ai</a>, and follow New Era Energy &amp; Digital on <a href=\"https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fnew-era-energy-digital%2F%3FviewAsMember%3Dtrue&amp;esheet=54434772&amp;newsitemid=20260226055146&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=2&amp;md5=1ecad507868836d3a660184d74019d74\" rel=\"nofollow noopener\" shape=\"rect\">LinkedIn</a> and <a href=\"https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fx.com%2FNUAI_IR&amp;esheet=54434772&amp;newsitemid=20260226055146&amp;lan=en-US&amp;anchor=X&amp;index=3&amp;md5=b45b3759df2ef0d6891ad3101c061993\" rel=\"nofollow noopener\" shape=\"rect\">X</a>.</p><p><b>Cautionary Note Regarding Forward-Looking Statements<br/></b>This press release contains “forward-looking statements.” Forward-looking statements reflect the current view about future events. When used in this press release, the words “anticipate,” “believe,” “estimate,” “expect,” “future,” “intend,” “plan” or the negative of these terms and similar expressions, as they relate to us or our management, identify forward-looking statements. Such statements include, but are not limited to, statements contained in this press release relating to our business strategy, our future operating results and liquidity and capital resources outlook. Forward-looking statements are based on our current expectations and assumptions regarding our business, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Our actual results may differ materially from those contemplated by the forward-looking statements. They are neither statements of historical fact nor guarantees of assurance of future performance. We caution you therefore against relying on any of these forward-looking statements. Important factors that could cause actual results to differ materially from those in the forward-looking statements include, without limitation: (a) our ability to effectively operate our business segments; (b) our ability to manage our research, development, expansion, growth and operating expenses; (c) our ability to evaluate and measure our business, prospects and performance metrics; (d) our ability to compete, directly and indirectly, and succeed in a highly competitive and evolving industry; (e) our ability to respond and adapt to changes in technology and customer behavior; (f) our ability to protect our intellectual property and to develop, maintain and enhance a strong brand; and (g) other factors (including the risks contained in the “Risk Factors” section of our Annual Report on Form 10-K for the fiscal year ended December 31, 2024). Should one or more of these risks or uncertainties materialize, or should the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended or planned. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We cannot guarantee future results, levels of activity, performance or achievements. Except as required by applicable law, including the securities laws of <location idsrc=\"xmltag.org\" value=\"LC/us\">the United States</location>, we do not intend to update any of the forward-looking statements to conform these statements to actual results.</p><p><img alt=\"\" loading=\"lazy\" src=\"https://cts.businesswire.com/ct/CT?id=bwnews&amp;sty=20260226055146r1&amp;sid=acqr8&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\"/><span class=\"bwct31415\"></span></p><p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: </span><span id=\"mmgallerylink-link\"><a href=\"https://www.businesswire.com/news/home/20260226055146/en/\" rel=\"nofollow noopener\">https://www.businesswire.com/news/home/20260226055146/en/</a></span></p><p>New Era Energy &amp; Digital, Inc. Investor and Media Contact:<br/>Investor Relations<br/><a href=\"mailto:Jonathan.Paterson@harbor-access.com\" rel=\"nofollow noopener\" shape=\"rect\">Jonathan.Paterson@harbor-access.com</a><br/>Tel: +1 475 477 9401</p><p>Source: New Era Energy &amp; Digital, Inc.</p></article>",
            "link": "https://www.stocktitan.net/news/NUAI/new-era-energy-digital-strengthens-integrated-power-positioning-at-9ep0koy0fhd0.html",
            "author": "stocktitan",
            "pub_date": "Thu, 26 Feb 2026 19:00:00 GMT",
            "source": "stocktitan",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Belfry Announces Strategic Partnership with Willis and Kayna to Support Physical Security Providers | WTW Stock News",
            "description": "<article class=\"article\"><div class=\"xn-content\"><p><span class=\"legendSpanClass\"><location idsrc=\"xmltag.org\" value=\"LU/us.ny.nyc\">NEW YORK</location></span>, <span class=\"legendSpanClass\">Feb. 26, 2026</span> /PRNewswire/ -- Belfry Software, a modern platform for physical security providers, has partnered with Willis, a <a class=\"symbol-link\" href=\"/overview/WTW/\" title=\"View WTW stock overview\">WTW</a> business (NASDAQ: <a class=\"symbol-link\" href=\"/overview/WTW/\" title=\"View WTW stock overview\">WTW</a>), to launch a digital insurance program tailored for Belfry customers. The program pairs Willis insurance expertise with award-winning Kayna insurance technology to deliver data-led, streamlined insurance solutions.</p><div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\"><p><a href=\"https://mma.prnewswire.com/media/2603420/Belfry_Logo_Indigo_Logo.html\" rel=\"nofollow noopener\" target=\"_blank\"><img alt=\"belfrysoftware.com (PRNewsfoto/Belfry)\" loading=\"lazy\" src=\"https://mma.prnewswire.com/media/2603420/Belfry_Logo_Indigo_Logo.jpg\" title=\"belfrysoftware.com (PRNewsfoto/Belfry)\"/></a></p></div><p>Belfry has transformed how security businesses operate by consolidating critical functions, including scheduling, timekeeping, payroll, billing, and more, into a single, integrated solution.</p><p>Willis is one of the world's leading insurance brokers and will serve as the placing broker for the program.</p><p>Kayna, Willis' technology partner, enables the distribution of Willis' security services insurance to Belfry customers by integrating a seamless insurance portal directly within the Belfry platform. Willis will utilize Kayna's technology to leverage real-time data to pre-fill forms and support quoting, saving users time and simplifying the procurement process.</p><p>As a result of this collaboration, an insurance portal will be included in the Belfry dashboard where customers can easily apply and receive a no-obligation insurance quote.</p><p class=\"prnml40\">\"At Belfry, we're building an all-in-one platform designed around the day-to-day realities of running a security company,\" said Jordan Wallach, Co-Founder &amp; CEO of Belfry. \"One of those realities is how difficult managing business insurance has been. It often takes weeks to gather and format the right payroll data for applications and audits, companies face surprise year-end adjustments because premiums are based on outdated payroll estimates, and finding the right coverage for complex risks isn't easy. By partnering Belfry's industry-specific payroll solution with Willis and Kayna, we're excited to help address challenges that have historically been a real pain for owners.\"</p><p>Willis has a team of insurance experts dedicated to ensuring Belfry customers can purchase robust coverage.</p><p>\"As part of our strategy to deliver tech-enabled insurance solutions, we're excited to partner with Belfry to embed coverage seamlessly into the security operator journey,\" stated Paul Lubbers, Head of US Affinity at Willis. \"Together, we aim to accelerate quoting and minimize premium audit risk, both of which are critical pain points and areas for improvements in the security industry.\" The partners share a commitment to support the success of Belfry customers by making it easier than ever to secure the right insurance coverage with minimal hassle so physical security operators can focus on their job with confidence.</p><p>Paul Prendergast, Co-Founder &amp; CEO of Kayna concluded, \"Backed by decades of Willis experience and expertise in underwriting and claims management, Belfry is taking an industry lead on delivering data-driven insurance and market choice for their platform customers. This is a winning formula for a great partnership and one that I'm delighted to see powered by Kayna technology.\"</p><p><b>About Belfry</b></p><p>Belfry is an operating system built specifically for security guard services, helping security companies manage scheduling, field supervision, officer performance, compliance, communications, and back-office operations in one platform. Belfry works with security guard firms across <location idsrc=\"xmltag.org\" value=\"LC/us\">the United States</location> to reduce manual work, improve operational visibility, protect profitability, and scale services more efficiently.</p><p>For more information about Belfry and its solutions, visit<a href=\"https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4628567-1&amp;h=3912673537&amp;u=http%3A%2F%2Fwww.belfrysoftware.com%2F&amp;a=%C2%A0\" rel=\"nofollow noopener\" target=\"_blank\"> </a><b><u><a href=\"https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4628567-1&amp;h=3102927570&amp;u=http%3A%2F%2Fwww.belfrysoftware.com%2F&amp;a=www.belfrysoftware.com\" rel=\"nofollow noopener\" target=\"_blank\">www.belfrysoftware.com</a></u></b>.</p><p><b>About <a class=\"symbol-link\" href=\"/overview/WTW/\" title=\"View WTW stock overview\">WTW</a> </b></p><p>At WTW (NASDAQ: WTW), we provide data-driven, insight-led solutions in the areas of people, risk and capital. Leveraging the global view and local expertise of our colleagues serving 140 countries and markets, we help organizations sharpen their strategy, enhance organizational resilience, motivate their workforce and maximize performance.</p><p>Working shoulder to shoulder with our clients, we uncover opportunities for sustainable success and provide perspective that moves you.</p><p><b>About Kayna</b></p><p>Kayna enables embedded insurance through vertical SaaS platforms. It provides the technology and data orchestration layer between carriers, brokers and any vertical SaaS platform to distribute insurance products that are directly relevant to platform customers.</p><p>SOURCE Belfry</p></div></article>",
            "link": "https://www.stocktitan.net/news/WTW/belfry-announces-strategic-partnership-with-willis-and-kayna-to-raepca5tpfi0.html",
            "author": "stocktitan",
            "pub_date": "Thu, 26 Feb 2026 19:00:00 GMT",
            "source": "stocktitan",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Elevance Health Announces Management Changes; CFO Mark Kaye to Expand Responsibilities to Include Carelon and Felicia Norwood to Lead Consolidated Health Benefits Organization | ELV Stock News",
            "description": "<article class=\"article\"><p> <location idsrc=\"xmltag.org\" value=\"LU/us.in.indpol\">INDIANAPOLIS</location>--(BUSINESS WIRE)--Elevance Health, Inc. (NYSE: <a class=\"symbol-link\" href=\"/overview/ELV/\" title=\"View ELV stock overview\">ELV</a>) today announced management changes designed to simplify decision-making and strengthen execution across Carelon and Health Benefits.</p><p>As part of these changes, Mark Kaye, Executive Vice President and Chief Financial Officer, will expand his responsibilities to include oversight of Carelon, the Company’s healthcare services operations including pharmacy services, behavioral health, value-based care, and care delivery capabilities. Carelon plays a critical role in advancing the Company’s strategy to lower the cost of care. Carelon’s operating priorities and client commitments remain unchanged.</p><p>Felicia Norwood, Executive Vice President and Chief Health Benefits Officer, will assume responsibility for the Company’s consolidated Health Benefits organization, bringing together the Company’s major Health Benefits businesses and core operating functions under a single accountable structure. This consolidation enhances coordination across Commercial and Government health benefits and supports a more consistent operating cadence across product, operations, and growth priorities.</p><p>Peter D. Haytaian has announced that he will transition from his role as Executive Vice President and President of Carelon effective May 4, 2026, in order to devote more time to family commitments. Haytaian will serve the Company as Special Advisor through December 31, 2026, to support an orderly leadership transition and ensure continuity across Carelon’s operations and client and partner relationships.</p><p>“Over the last several years, we have continued to evolve how we operate to meet the changing needs of healthcare and deliver for our customers, members, and clients,” said Gail Boudreaux, President and Chief Executive Officer of Elevance Health. “These management changes support disciplined execution and help us move with greater clarity and coordination as we continue to scale. I also want to thank Pete for his leadership and his commitment to supporting a smooth transition.”</p><p>“I look forward to leading the Carelon team as we build on our strong foundation, deliver for clients and partners, and execute with discipline that supports sustainable growth and long-term value,” said Kaye.</p><p>Norwood added, “Bringing Health Benefits together under a single accountable structure strengthens coordination and execution as we continue delivering for members and customers.”</p><p><b>About Elevance Health</b></p><p>Elevance Health is a lifetime, trusted health partner whose purpose is to improve the health of humanity. The company supports consumers, families, and communities across the entire healthcare journey – connecting them to the care, support, and resources they need to lead better lives. Elevance Health’s companies serve approximately 104 million consumers through a diverse portfolio of industry-leading medical, pharmacy, behavioral, clinical, home health, and complex care solutions. For more information, please visit <a href=\"https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.elevancehealth.com%2F&amp;esheet=54434506&amp;newsitemid=20260226217741&amp;lan=en-US&amp;anchor=www.elevancehealth.com&amp;index=1&amp;md5=0698af582815dee8a4b5607c9ed3a3f7\" rel=\"nofollow noopener\" shape=\"rect\">www.elevancehealth.com</a> or follow us <a href=\"https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.twitter.com%2F%40elevancehealth&amp;esheet=54434506&amp;newsitemid=20260226217741&amp;lan=en-US&amp;anchor=%40ElevanceHealth&amp;index=2&amp;md5=c49c830f279f7ade422add99605cba39\" rel=\"nofollow noopener\" shape=\"rect\">@ElevanceHealth</a> on X and <a href=\"https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Felevance-health%2F&amp;esheet=54434506&amp;newsitemid=20260226217741&amp;lan=en-US&amp;anchor=Elevance+Health&amp;index=3&amp;md5=5da3334c76bd429ccaa80877a50e0459\" rel=\"nofollow noopener\" shape=\"rect\">Elevance Health</a> on LinkedIn.</p><p><b>Forward-Looking Statements</b></p><p><i>This document contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect our views about future events and financial performance and are generally not historical facts. Words such as “expect,” “feel,” “believe,” “will,” “may,” “should,” “anticipate,” “intend,” “estimate,” “project,” “forecast,” “plan,” “potential,” “predict” and similar expressions are intended to identify forward-looking statements. These statements include, but are not limited to: financial projections and estimates and their underlying assumptions; statements regarding plans, objectives and expectations with respect to future operations, products and services; and statements regarding future performance. Such statements are subject to certain risks and uncertainties, many of which are difficult to predict and generally beyond our control, that could cause actual results to differ materially from those expressed in, or implied or projected by, the forward-looking statements. You are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date hereof. You are also urged to carefully review and consider the various risks and other disclosures discussed in our reports filed with the <location idsrc=\"xmltag.org\" value=\"LC/us\">U.S.</location> Securities and Exchange Commission from time to time, which attempt to advise interested parties of the factors that affect our business. Except to the extent required by law, we do not update or revise any forward-looking statements to reflect events or circumstances occurring after the date hereof. These risks and uncertainties include, but are not limited to: trends in healthcare costs and utilization rates; reduced enrollment; our ability to secure and implement sufficient premium rates; the impact of large scale medical emergencies, such as public health epidemics and pandemics, and other catastrophes; the impact of new or changes in existing federal, state and international laws or regulations, including laws and regulations impacting healthcare, insurance, pharmacy services and other diversified products and services, or their enforcement or application; the impact of cyber-attacks or other privacy or data security incidents or our failure to comply with any privacy, data or security laws or regulations, including any investigations, claims or litigation related thereto; failure to effectively maintain and modernize our information systems; failure of our information systems or technology, including artificial intelligence, to operate as intended; failure to effectively maintain the availability and integrity of our data; changes in economic and market conditions, as well as regulations that may negatively affect our liquidity and investment portfolios; competitive pressures and our ability to adapt to changes in the industry and develop and implement strategic growth opportunities; risks and uncertainties regarding Medicare and Medicaid programs, including those related to non-compliance with the complex regulations imposed thereon; our ability to maintain and achieve improvement in Centers for Medicare and Medicaid Services Star Ratings and other quality scores and funding risks with respect to revenue received from participation therein; a negative change in our healthcare product mix; costs and other liabilities associated with litigation, government investigations, audits or reviews; our ability to contract with providers on cost-effective and competitive terms; risks associated with providing healthcare, pharmacy and other diversified products and services, including medical malpractice or professional liability claims and non-compliance by any party with the pharmacy services agreement between us and CaremarkPCS Health, L.L.C.; the effects of any negative publicity or sentiment related to the health benefits industry in general or us in particular; risks associated with mergers, acquisitions, joint ventures and strategic alliances; possible impairment of the value of our intangible assets if future results do not adequately support goodwill and other intangible assets; possible restrictions in the payment of dividends from our subsidiaries and increases in required minimum levels of capital; our ability to repurchase shares of our common stock and pay dividends on our common stock due to the adequacy of our cash flow and earnings and other considerations; the potential negative effect from our substantial amount of outstanding indebtedness and the risk that increased interest rates or market volatility could impact our access to or further increase the cost of financing; a downgrade in our financial strength ratings; events that may negatively affect our licenses with the Blue Cross and Blue Shield Association; intense competition to attract and retain employees; risks associated with our international operations; and various laws and provisions in our governing documents that may prevent or discourage takeovers and business combinations.</i></p><p><img alt=\"\" loading=\"lazy\" src=\"https://cts.businesswire.com/ct/CT?id=bwnews&amp;sty=20260226217741r1&amp;sid=acqr8&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\"/><span class=\"bwct31415\"></span></p><p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: </span><span id=\"mmgallerylink-link\"><a href=\"https://www.businesswire.com/news/home/20260226217741/en/\" rel=\"nofollow noopener\">https://www.businesswire.com/news/home/20260226217741/en/</a></span></p><p>Elevance Health Contacts:<br/><b>Investor Relations:</b><br/>Nathan Rich<br/><a href=\"mailto:Investor.Relations@elevancehealth.com\" rel=\"nofollow noopener\" shape=\"rect\">Investor.Relations@elevancehealth.com</a></p><p><b>Media Contact:</b><br/>Leslie Porras<br/><a href=\"mailto:Leslie.Porras@elevancehealth.com\" rel=\"nofollow noopener\" shape=\"rect\">Leslie.Porras@elevancehealth.com</a></p><p>Source: Elevance Health, Inc.</p></article>",
            "link": "https://www.stocktitan.net/news/ELV/elevance-health-announces-management-changes-cfo-mark-kaye-to-expand-j9uh8tn8h78l.html",
            "author": "stocktitan",
            "pub_date": "Thu, 26 Feb 2026 20:02:00 GMT",
            "source": "stocktitan",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Seven Years Strong: Ethan Allen’s Mexico Plant Honored Again for Socially and Environmentally Responsible Practices | ETD Stock News",
            "description": "<article class=\"article\"><p>DANBURY, Conn., Feb.  26, 2026  (GLOBE NEWSWIRE) -- Ethan Allen’s upholstery manufacturing plant in Silao, Guanajuato, Mexico, has once again been recognized as “Empresa Socialmente Responsible” (Environmentally and Socially Responsible), marking seven consecutive years of acknowledgment by the Mexican Center for Corporate Philanthropy and the Alliance for Corporate Social Responsibility.</p> <p>“Ethan Allen’s commitment to social responsibility and sustainability is exemplified by the efforts of our Silao upholstery team, and we are pleased that they’ve been recognized once again,” stated Farooq Kathwari, Ethan Allen Chairman, President and CEO. “Their commitment to quality and exceptional service safeguards Ethan Allen’s 94-year legacy of exceptional craftsmanship.”</p> <p>Beyond its role in producing hand-tailored upholstery and supplying cut-and-sewn materials, the Silao plant maintains a strong focus on employee well‑being. Associates receive transportation to and from work, healthy meals, and access to a clinic where doctors and nurses provide medical care, vaccinations, and over‑the‑counter medications.</p> <p>Both the Mexican Center for Corporate Philanthropy and the Alliance for Corporate Social Responsibility work to highlight how corporate social responsibility generates both social benefits and strategic advantages for organizations. “Our Silao team is a cornerstone of Ethan Allen’s commitment to North American manufacturing,” Mr. Kathwari noted, “and I congratulate them on this extraordinary achievement.”</p> <p><strong>ABOUT ETHAN ALLEN</strong><br/>Ethan Allen (NYSE:<a class=\"symbol-link\" href=\"/overview/ETD/\" title=\"View ETD stock overview\">ETD</a>), named America's #1 Premium Furniture Retailer by <em>Newsweek</em> for three consecutive years, is a leading interior design destination combining state-of-the-art technology with personal service. Ethan Allen design centers, which represent a mix of Company-operated and independent licensee locations, offer complimentary interior design service and sell a full range of home furnishings, including custom furniture and artisan-crafted accents for every room in the home. Vertically integrated from product design through logistics, the Company manufactures most of its custom-crafted products in its North American manufacturing facilities and has been recognized for product quality and craftsmanship since 1932. Learn more at www.ethanallen.com and follow Ethan Allen on Facebook, Instagram, and LinkedIn.</p> <p>CONTACT:<br/>Catherine Plaisted, Senior Vice President, Marketing<br/><a href=\"https://www.globenewswire.com/Tracker?data=6I1XyfS6P7elrlln3_U-bQ_3NW-pvcGaaQ0sM_7s7DdS3CNm51TzPlg55MRAQ-N_HbQBFlpQ2QnN3bhAgR8Ke9ccQxpZDZsFdl0Oe-Gntc4yb-CiN7gswYIfGn8v0CU-qWFfMgUCyXUy-I_neNxQhg==\" rel=\"nofollow noopener\" target=\"_blank\">catherine.plaisted@ethanallen.com</a></p> <p>A photo accompanying this announcement is available at <a href=\"https://www.globenewswire.com/Tracker?data=9k8iRyDIQ_8nEvcxWGhMaTLkXR2B-gcPhLivwGBaEkM_N42vxgcleXf3Dlvlk5RMgIQ0w09G_gKxrjNKPz5eIhE6Ee3a5hOjgg8yhFaC5r_WQPb-39p-2H7PT3epr05r6oh04s05crVs3cQ2GNg_b0O_bOWRnL31pwz2AXOnuzEXGJ1h5k4VzAdNUS8rEqFgu2E8JArRZ-Db9Z1liOyuntZjkVXv2ozIv3LWrLkAOBnb4D0nesW_CvjAVjvbt-p8wFUMmYmK-TFmIGENSvOTuA==\" rel=\"nofollow noopener\" target=\"_blank\">https://www.globenewswire.com/NewsRoom/AttachmentNg/641fafff-7dcd-4eef-95a2-c4249037d878</a></p> <img alt=\"\" class=\"__GNW8366DE3E__IMG\" loading=\"lazy\" src=\"https://www.globenewswire.com/newsroom/ti?nf=OTY2MjM0MCM3NDU3ODYxIzIwMTk1NDA=\"/> <br/><img alt=\"\" loading=\"lazy\" referrerpolicy=\"no-referrer-when-downgrade\" src=\"https://ml.globenewswire.com/media/NmE2N2Y0MmUtYWVlZC00M2EyLTkxMjUtYzE4NjEyNTRhZWZjLTEwMzEyMDQtMjAyNi0wMi0yNi1lbg==/tiny/Ethan-Allen.png\"/></article>",
            "link": "https://www.stocktitan.net/news/ETD/seven-years-strong-ethan-allen-s-mexico-plant-honored-again-for-xa8lesz9r9rx.html",
            "author": "stocktitan",
            "pub_date": "Thu, 26 Feb 2026 18:44:00 GMT",
            "source": "stocktitan",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Eaton increases quarterly dividend to $1.10 per share | ETN Stock News",
            "description": "<article class=\"article\"><p><b>Dividend payable March 27, 2026</b></p><p> <location idsrc=\"xmltag.org\" value=\"LU/ie..dublin\">DUBLIN</location>--(BUSINESS WIRE)--The Board of Directors of intelligent power management company Eaton (NYSE:<a class=\"symbol-link\" href=\"/overview/ETN/\" title=\"View ETN stock overview\">ETN</a>) today declared a quarterly dividend of <money><money>$1.10</money></money> per ordinary share, an increase of <percent>6%</percent> over its last quarterly dividend. The dividend is payable March 27, 2026, to shareholders of record at the close of business on March 10, 2026. Eaton has paid dividends on its shares every year since 1923.</p><p>Eaton is an intelligent power management company dedicated to protecting the environment and improving the quality of life for people everywhere. We make products for the data center, utility, industrial, commercial and institutional, machine building, residential, aerospace and mobility markets. We are guided by our commitment to do business right, to operate sustainably and to help our customers manage power ─ today and well into the future. By capitalizing on the global growth trends of electrification and digitalization, we’re helping to solve the world’s most urgent power management challenges and building a more sustainable society for people today and generations to come.</p><p>Founded in 1911, Eaton has continuously evolved to meet the changing and expanding needs of our stakeholders. With revenues of <money><money>$27.4 billion</money></money> in 2025, the company serves customers in 180 countries. For more information, visit <a href=\"https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.eaton.com&amp;esheet=54434324&amp;newsitemid=20260226327789&amp;lan=en-US&amp;anchor=www.eaton.com&amp;index=1&amp;md5=4838d07a22cc0b7366f2099110f9bcf9\" rel=\"nofollow noopener\" shape=\"rect\">www.eaton.com</a>. Follow us on <a href=\"https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Featon%2F&amp;esheet=54434324&amp;newsitemid=20260226327789&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=2&amp;md5=9f82aea6c2d37998afc74082ffc67368\" rel=\"nofollow noopener\" shape=\"rect\">LinkedIn</a>.</p><p><img alt=\"\" loading=\"lazy\" src=\"https://cts.businesswire.com/ct/CT?id=bwnews&amp;sty=20260226327789r1&amp;sid=acqr8&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\"/><span class=\"bwct31415\"></span></p><p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: </span><span id=\"mmgallerylink-link\"><a href=\"https://www.businesswire.com/news/home/20260226327789/en/\" rel=\"nofollow noopener\">https://www.businesswire.com/news/home/20260226327789/en/</a></span></p><p>Jennifer Tolhurst<br/>+1 (440) 523-4006<br/><a href=\"mailto:jennifertolhurst@eaton.com\" rel=\"nofollow noopener\" shape=\"rect\">jennifertolhurst@eaton.com</a></p><p>Source: Eaton</p></article>",
            "link": "https://www.stocktitan.net/news/ETN/eaton-increases-quarterly-dividend-to-1-10-per-ys3rdd732qbw.html",
            "author": "stocktitan",
            "pub_date": "Thu, 26 Feb 2026 18:49:00 GMT",
            "source": "stocktitan",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Cycurion, Inc. Adjourns Special Meeting of Stockholders Until March 19, 2026 | CYCU Stock News",
            "description": "<article class=\"article\"><p align=\"justify\">MCLEAN, Va., Feb.  26, 2026  (GLOBE NEWSWIRE) -- Cycurion, Inc. (Nasdaq: <a class=\"symbol-link\" href=\"/overview/CYCU/\" title=\"View CYCU stock overview\">CYCU</a>) (“Cycurion” or the “Company”), a trusted leader in IT cybersecurity solutions, today adjourned its special meeting of stockholders (the “Special Meeting”) until Thursday, March 19, 2026 at 12:00 p.m. Eastern Time in order to provide Cycurion stockholders with additional time to cast their votes. The Special Meeting was originally scheduled for today; however, the number of votes cast was less than the number of shares required to constitute a quorum for the Special Meeting.</p> <p align=\"justify\">The purpose of the Special Meeting is for Cycurion stockholders to approve, pursuant to Nasdaq Listing Rule 5635(d), the issuance of up to an aggregate of 3,314,920 shares of the Company’s common stock upon the exercise of certain common stock purchase warrants issued in connection with our private placement that closed on December 5, 2025, that may be equal to or exceed <percent>20%</percent> of our outstanding shares of common stock immediately prior to such offering. The proposals to be voted on by the Cycurion stockholders at the adjourned Special Meeting are more fully described in the Company’s definitive proxy statement filed with the U.S. Securities and Exchange Commission (the “SEC”) on February 2, 2026.</p> <p align=\"justify\">The record date for the Special Meeting remains January 21, 2026 and will apply to the reconvened Special Meeting on March 19, 2026. Proxies previously submitted in respect of the Special Meeting will be voted at the reconvened Special Meeting unless properly revoked. Stockholders who have previously submitted their proxy or otherwise voted need not take any action. For stockholders who have not yet cast their votes, Cycurion encourages them to vote their shares now. Instructions for how to vote by proxy at the meeting, even if a stockholder is unable to attend the meeting, are included in the definitive proxy statement. For more information on how to vote, please contact Cycurion’s proxy solicitor, D.F. King &amp; Co., Inc. </p> <p align=\"justify\"><strong>About Cycurion</strong></p> <p align=\"justify\">Based in McLean, Virginia, Cycurion (NASDAQ: <a class=\"symbol-link\" href=\"/overview/CYCU/\" title=\"View CYCU stock overview\">CYCU</a>) is a forward-thinking provider of IT cybersecurity solutions and AI, committed to delivering secure, reliable, and innovative services to clients worldwide. Specializing in cybersecurity, program management, and business continuity, Cycurion harnesses its AI-enhanced ARx platform and expert team to empower clients and safeguard their operations. Along with its subsidiaries, Axxum Technologies LLC, Cloudburst Security LLC, and Cycurion Innovation, Inc., Cycurion serves government, healthcare, and corporate clients committed to securing the digital future. For more information, visit www.cycurion.com.</p> <p><strong><u>Forward-Looking Statements</u></strong></p> <p align=\"justify\">This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to the operations and prospective growth of Cycurion’s business.</p> <p align=\"justify\">Certain statements in this press release that are not historical facts are forward-looking statements within the meaning of Section 27A of the Securities Exchange Act of 1934, as amended. Any statements contained in this press release that are not statements of historical fact may be deemed forward-looking statements. Such statements include, but are not limited to, statements regarding the anticipated closing of the offering; the Company’s anticipated use of proceeds from the offering; the acceleration of the Company’s inorganic growth strategy; the continued execution on the Company’s backlog; and other statements that are not historical facts, including statements which may be accompanied by words such as “continue,” “will,” “may,” “could,” “should,” “expect,” “expected,” “plans,” “intend,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” and similar expressions are intended to identify such forward-looking statements. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the forward-looking statements, many of which are generally outside the control of Cycurion and are difficult to predict. Examples of such risks and uncertainties include, but are not limited to, the outcomes of the Company’s investigations, any potential legal proceedings, or the future performance of the Company’s stock. Additional factors that could cause actual results to differ materially from those expressed or implied in the forward-looking statements can be found in the most recent annual report on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K filed by Cycurion with the SEC. Cycurion anticipates that subsequent events and developments may cause its plans, intentions, and expectations to change. Cycurion assumes no obligation, and it specifically disclaims any intention or obligation, to update any forward-looking statements, whether as a result of new information, future events, or otherwise, except as expressly required by law. Forward-looking statements speak only as of the date they are made and should not be relied upon as representing Cycurion’s plans and expectations as of any subsequent date.</p> <p>Cycurion Investor Relations:<br/>(888) 341-6680<br/>investors@cycurion.com</p> <p>Cycurion Media Relations:<br/>(888) 341-6680<br/>media@cycurion.com</p> <img alt=\"\" class=\"__GNW8366DE3E__IMG\" loading=\"lazy\" src=\"https://www.globenewswire.com/newsroom/ti?nf=OTY2MjM2MyM3NDU3ODUyIzIyOTg5MDA=\"/> <br/><img alt=\"\" loading=\"lazy\" referrerpolicy=\"no-referrer-when-downgrade\" src=\"https://ml.globenewswire.com/media/NWJjNzJlMmItYTI3NS00NjBkLWJjYWQtMGY4YTIxNDgzMjRkLTEzMTA0NTAtMjAyNi0wMi0yNi1lbg==/tiny/Cycurion.png\"/></article>",
            "link": "https://www.stocktitan.net/news/CYCU/cycurion-inc-adjourns-special-meeting-of-stockholders-until-march-19-irm2kyo0c4ml.html",
            "author": "stocktitan",
            "pub_date": "Thu, 26 Feb 2026 20:00:00 GMT",
            "source": "stocktitan",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Albany Engineered Composites President Chris Stone to Join Executive Panel on Industrializing Next-Generation Aerospace Composites | AIN Stock News",
            "description": "<article class=\"article\"><p> <location idsrc=\"xmltag.org\" value=\"LU/us.nh.portsm\">PORTSMOUTH, N.H.</location>--(BUSINESS WIRE)--Albany Engineered Composites (AEC), a world leader in advanced composite solutions for the aerospace and defense industry, today announces president Chris Stone will join an executive panel at Aerolambda’s “The Aerospace Event” on Monday, March 2, at 3 p.m. PT.</p><p>The panel, “C-Suite Views from Leading Aerospace Composites Companies,” examines demand trends, supply chain dynamics and technology developments shaping the aerospace composites industry.</p><p>“As aerospace platforms evolve and production rates accelerate, advanced composites are essential to achieving performance, weight and affordability targets at scale,” said Stone. “At AEC, we focus on industrializing high-performance composite solutions — from metallic replacement opportunities to extreme-environment applications — to ensure we are ready for the next generation of aerospace and defense programs as a strategic supply chain partner to our customers.”</p><p>The discussion explores demand for composite structures across commercial aerospace, defense and space systems, including the growing need for lightweight materials outperforming legacy metals while enabling higher-rate production. Panelists also examine how evolving supplier roles, increased OEM insourcing and the push for resilient domestic supply chains reshape composite manufacturing strategies.</p><p><b>About Albany Engineered Composites<br/></b>Albany Engineered Composites (AEC), a subsidiary of Albany International Corp. (NYSE: <location idsrc=\"xmltag.org\" value=\"LS/fr.an\">AIN</location>), designs and manufactures advanced engineered composite components for engine and airframe applications in commercial and military aircraft, missiles and unmanned vehicles. AEC’s specialty composite solutions enable current and next-generation aircraft to perform better while being more fuel efficient, cost effective and environmentally friendly.</p><p><img alt=\"\" loading=\"lazy\" src=\"https://cts.businesswire.com/ct/CT?id=bwnews&amp;sty=20260226918106r1&amp;sid=acqr8&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\"/><span class=\"bwct31415\"></span></p><p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: </span><span id=\"mmgallerylink-link\"><a href=\"https://www.businesswire.com/news/home/20260226918106/en/\" rel=\"nofollow noopener\">https://www.businesswire.com/news/home/20260226918106/en/</a></span></p><p><b>Media</b><br/>Bryan Warren<br/>Senior Marketing &amp; Communications Manager<br/>817-682-6786</p><p>Source: Albany Engineered Composites</p></article>",
            "link": "https://www.stocktitan.net/news/AIN/albany-engineered-composites-president-chris-stone-to-join-executive-u04vooubzu0g.html",
            "author": "stocktitan",
            "pub_date": "Thu, 26 Feb 2026 19:47:00 GMT",
            "source": "stocktitan",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "DraftKings Secures License To Provide Its Top-Rated Online Sportsbook App in Arkansas on Behalf of Southland Casino Hotel | DKNG Stock News",
            "description": "<article class=\"article\"><p class=\"bwalignc\"><i>Agreement with Southland Casino Hotel paves the way for DraftKings to enter <location idsrc=\"xmltag.org\" value=\"LS/us.ar\">Arkansas</location></i></p><p> <location idsrc=\"xmltag.org\" value=\"LU/us.ma.boston\">BOSTON</location>--(BUSINESS WIRE)--DraftKings Inc. (Nasdaq: <a class=\"symbol-link\" href=\"/overview/DKNG/\" title=\"View DKNG stock overview\">DKNG</a>) (“DraftKings”) today announced that the Arkansas Racing Commission has approved the company for licensure, allowing DraftKings to soon launch its top-rated online sportsbook in the state, on behalf of Southland Casino Hotel, pending final regulatory approvals. The pending launch follows a market access agreement with Southland Casino Hotel. The addition of <location idsrc=\"xmltag.org\" value=\"LS/us.ar\">Arkansas</location> expands the access of DraftKings Sportsbook to more than 2 million adult residents in the state, increasing coverage of the product to <percent>53%</percent> of the <location idsrc=\"xmltag.org\" value=\"LC/us\">U.S.</location> population.</p><p>Eligible customers in <location idsrc=\"xmltag.org\" value=\"LS/us.ar\">Arkansas</location> will have access to DraftKings’ industry-leading online sportsbook, featuring a wide range of betting options including same-game parlays, in-game wagering, special odds boosts, and more. Customers will also have access to DraftKings’ robust suite of responsible gaming tools and resources.</p><p>“We’re excited to team up with Southland Casino Hotel to bring DraftKings’ top-rated mobile sportsbook to <location idsrc=\"xmltag.org\" value=\"LS/us.ar\">Arkansas</location> and introduce fans to our best-in-class sports betting offering,” said Gregory Karamitis, DraftKings Executive Vice President and General Manager of Sports. “As March Madness approaches and several major sports are underway, we look forward to serving <location idsrc=\"xmltag.org\" value=\"LS/us.ar\">Arkansas</location> customers with innovative features, including our No. 1 live betting experience and a continued commitment to responsible gaming.”</p><p><location idsrc=\"xmltag.org\" value=\"LS/us.ar\">Arkansas</location> will mark the 30th <location idsrc=\"xmltag.org\" value=\"LC/us\">U.S.</location> state, in addition to <location idsrc=\"xmltag.org\" value=\"LU/us.dc.wash\">Washington, D.C.</location>, <location idsrc=\"xmltag.org\" value=\"LS/ca.on\">Ontario, Canada</location>, and <location idsrc=\"xmltag.org\" value=\"LC/pr\">Puerto Rico</location>, where DraftKings operates regulated sports betting.</p><p>DraftKings offers a comprehensive suite of responsible gaming tools, including My Stat Sheet, which allows customers to track personalized gaming activity, and My Budget Builder, which helps customers set custom limits and reminders through a guided, easy-to-use experience.</p><p>More information about DraftKings is available at <a href=\"https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.draftkings.com&amp;esheet=54434488&amp;newsitemid=20260226707290&amp;lan=en-US&amp;anchor=www.draftkings.com&amp;index=1&amp;md5=81f4d47ae1e52e984f953b4807fc5da9\" rel=\"nofollow noopener\" shape=\"rect\">www.draftkings.com</a> and fans can download the DraftKings mobile apps via iOS and Android <a href=\"https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.draftkings.com%2Fmobileapps&amp;esheet=54434488&amp;newsitemid=20260226707290&amp;lan=en-US&amp;anchor=here&amp;index=2&amp;md5=e48c5b9f1a01f756e13001e57cf1a2a1\" rel=\"nofollow noopener\" shape=\"rect\">here</a>.</p><p><b>About DraftKings</b></p><p>DraftKings Inc. is a digital sports entertainment and gaming company created to be the Ultimate Host and fuel the competitive spirit of sports fans with products that range across daily fantasy, regulated gaming and digital media. Headquartered in <location idsrc=\"xmltag.org\" value=\"LU/us.ma.boston\">Boston</location> and launched in 2012 by Jason Robins, Matt Kalish and Paul Liberman, DraftKings is the only <location idsrc=\"xmltag.org\" value=\"LC/us\">U.S.</location>-based vertically integrated sports betting operator. DraftKings’ mission is to make life more exciting by responsibly creating the world’s favorite real-money games, betting experiences and event contracts trading. DraftKings Sportsbook is live with mobile and/or retail sports betting operations pursuant to regulations in 29 states, <location idsrc=\"xmltag.org\" value=\"LU/us.dc.wash\">Washington, D.C.</location>, <location idsrc=\"xmltag.org\" value=\"LC/pr\">Puerto Rico</location>, and <location idsrc=\"xmltag.org\" value=\"LS/ca.on\">Ontario, Canada</location>. The Company operates iGaming pursuant to regulations in five states and in <location idsrc=\"xmltag.org\" value=\"LS/ca.on\">Ontario, Canada</location> under its DraftKings brand and pursuant to regulations in four states and in <location idsrc=\"xmltag.org\" value=\"LS/ca.on\">Ontario, Canada</location>, under its Golden Nugget Online Gaming brand. DraftKings also owns Jackpocket, the leading digital lottery courier app in <location idsrc=\"xmltag.org\" value=\"LC/us\">the United States</location>. DraftKings’ daily fantasy sports product is available in 44 states, <location idsrc=\"xmltag.org\" value=\"LU/us.dc.wash\">Washington, D.C.</location>, and certain Canadian provinces. DraftKings is both an official sports betting and daily fantasy partner of the NFL, NHL, PGA TOUR, and WNBA, as well as an official daily fantasy partner of NASCAR, an official sports betting partner of the NBA and an authorized gaming operator of MLB. In addition, DraftKings owns and operates DraftKings Network, a multi-platform content ecosystem. DraftKings is committed to being a responsible steward of this new era in real-money gaming by developing and promoting educational information and tools to help all players enjoy our products responsibly.</p><p><b>Forward-Looking Statements</b></p><p>Certain statements made in this press release are “forward looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. When used in this press release, the words “estimates,” “projected,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” ”would,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside DraftKings’ control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. For a discussion of additional risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see DraftKings’ filings with the Securities and Exchange Commission. DraftKings does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.</p><p><img alt=\"\" loading=\"lazy\" src=\"https://cts.businesswire.com/ct/CT?id=bwnews&amp;sty=20260226707290r1&amp;sid=acqr8&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\"/><span class=\"bwct31415\"></span></p><p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: </span><span id=\"mmgallerylink-link\"><a href=\"https://www.businesswire.com/news/home/20260226707290/en/\" rel=\"nofollow noopener\">https://www.businesswire.com/news/home/20260226707290/en/</a></span></p><p><a href=\"mailto:media@draftkings.com\" rel=\"nofollow noopener\" shape=\"rect\">media@draftkings.com</a><br/><a href=\"https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2FDraftKingsNews&amp;esheet=54434488&amp;newsitemid=20260226707290&amp;lan=en-US&amp;anchor=%40DraftKingsNews&amp;index=3&amp;md5=78f36b838ae06f0adb619043c20010ab\" rel=\"nofollow noopener\" shape=\"rect\">@DraftKingsNews</a></p><p>Source: DK Crown Holdings Inc.</p></article>",
            "link": "https://www.stocktitan.net/news/DKNG/draft-kings-secures-license-to-provide-its-top-rated-online-jb4bml1znl75.html",
            "author": "stocktitan",
            "pub_date": "Thu, 26 Feb 2026 19:48:00 GMT",
            "source": "stocktitan",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Toll Brothers at Everly New Luxury Home Community Coming Soon to Spartanburg, South Carolina | TOL Stock News",
            "description": "<article class=\"article\"><p><strong>New Toll Brothers homes will offer personalization options and onsite resort-style amenities in a master-planned setting</strong></p><p align=\"left\">SPARTANBURG, S.C., Feb.  26, 2026  (GLOBE NEWSWIRE) -- <a href=\"https://www.globenewswire.com/Tracker?data=wFuRYmEQtOiiaXDR6PxGfEZU4BtoUE6-zyoENUpmpho1xOi9C5TlL4Z7ODYM9eZhJV30c_qxo-d2buVJyox7dd-yfXSOLj69XSid7Sk7nrM=\" rel=\"nofollow noopener\" target=\"_blank\">Toll Brothers, Inc.</a> (NYSE:<a class=\"symbol-link\" href=\"/overview/TOL/\" title=\"View TOL stock overview\">TOL</a>), the nation's leading builder of luxury homes, today announced its latest luxury home community, <a href=\"https://www.globenewswire.com/Tracker?data=wFuRYmEQtOiiaXDR6PxGfC__HhNEEPVOrJLUSDw9C8HfwDqPNbhpDuBrwgHOtSVaeqr_yXfxPtvxtuhfstIilwpSGkVXC7AuyGLTqQ5W9_pHMO6dJMkg2WfEUjS7JJuGxPoS24Cq0oFNb0hKFB10DpRPaqzRYQIPXtCneRBnTjf6cl_qkMpDXk0O8KkiQm-Z\" rel=\"nofollow noopener\" target=\"_blank\">Toll Brothers at Everly</a>, is coming soon to Spartanburg, South Carolina. Nestled within a master-planned neighborhood directly across from Carolina Country Club, this community will showcase modern home designs, exceptional personalization options, and unparalleled amenities. Site work is underway at 7177 Myrtle Burl Way in Spartanburg, and the community is anticipated to open for sale in summer 2026.</p> <p align=\"center\"><img alt=\"Toll Brothers at Everly\" data-caption=\"Coming Soon to Spartanburg, South Carolina, Toll Brothers at Everly will offer single-family homes with access to exceptional amenities.\" data-dpi=\"72\" data-filename=\"Parklynn Hills_Fielder_Open Layout_3_CC_RET_RGB.jpg\" height=\"400\" loading=\"lazy\" src=\"https://ml.globenewswire.com/Resource/Download/7114915d-1253-4e65-9854-788750d0bbc0/parklynn-hills-fielder-open-layout-3-cc-ret-rgb.jpg\" width=\"600\"/><br/></p> <p align=\"left\">Situated in an idyllic location, Toll Brothers at Everly will feature luxury homes on large home sites priced from the low <money>$700,000</money>s. The home designs will include versatile floor plans with first- or second-floor primary bedroom suites, covered patios, and open-concept living spaces. The community’s breathtaking 12-acre lake and three resort-style clubhouses, complete with a fitness center and pool, will offer residents a vibrant and active lifestyle.</p> <p align=\"left\">Toll Brothers customers will experience one-stop shopping at the <a href=\"https://www.globenewswire.com/Tracker?data=wFuRYmEQtOiiaXDR6PxGfAaD-KbpvuJtio1kAkA3i5TdTh5AE0bfanyzzomlQAjD51el4j2P9xyFtn019ZEATH2ktUelo8L5cRtpfvoC1Wd7cqUBjwJV-6ir93JSfdTT\" rel=\"nofollow noopener\" target=\"_blank\">Toll Brothers Design Studio</a>. The state-of-the-art Design Studio allows home shoppers to choose from a wide array of selections to personalize their dream home with the assistance of Toll Brothers professional Design Consultants.</p> <p align=\"center\"><img alt=\"Toll Brothers at Everly\" data-caption='\"Toll Brothers at Everly will deliver an unparalleled living experience with its luxurious home designs on large home sites within a picturesque setting in Spartanburg,\" said Jason Simpson, Group President of Toll Brothers in South Carolina. ' data-dpi=\"72\" data-filename=\"Coachman Reserve_Alisa Farmhouse_Office_1 (1).jpg\" height=\"400\" loading=\"lazy\" src=\"https://ml.globenewswire.com/Resource/Download/b6701153-1ad6-4f85-aeca-0e217bf91fe8/coachman-reserve-alisa-farmhouse-office-1-1-.jpg\" width=\"600\"/><br/></p> <p align=\"left\">\"Toll Brothers at Everly will deliver an unparalleled living experience with its luxurious home designs on large home sites within a picturesque setting in Spartanburg,\" said Jason Simpson, Group President of Toll Brothers in South Carolina. \"This community is thoughtfully designed to provide our residents with the perfect balance of luxury and convenience.\"</p> <p align=\"left\">Homeowners living in Toll Brothers at Everly will enjoy proximity to top-rated golf courses, local shopping, and highly ranked schools in Spartanburg County School District No. 6. Everyday conveniences and the excitement of downtown Spartanburg are just minutes away, making this community an ideal destination for luxury living.</p> <p align=\"center\"><img alt=\"Toll Brothers at Everly\" data-caption=\"Homeowners living in Toll Brothers at Everly will enjoy proximity to top-rated golf courses, local shopping, and highly ranked schools.\" data-dpi=\"72\" data-filename=\"Parklynn Hills_Fielder_Primary bed_9.jpg\" height=\"400\" loading=\"lazy\" src=\"https://ml.globenewswire.com/Resource/Download/3a6d5491-2423-4e8f-af31-f3f867ff0757/parklynn-hills-fielder-primary-bed-9.jpg\" width=\"600\"/><br/></p> <p align=\"left\">For more information and to join the Toll Brothers interest list for Toll Brothers at Everly, call (866) 232-1719 or visit <a href=\"https://www.globenewswire.com/Tracker?data=ouEVesVyAswLAI9Td8vCgS2bud5iRtxhCHRaIQwQycMiWrLAD4dyuUx9OjCfcl87y2-J9RCWPNOS1-qPf8DTdY7Og7174_mWXkKAuZCqCbQ=\" rel=\"nofollow noopener\" target=\"_blank\">TollBrothers.com/SC</a>.</p> <p align=\"left\"><strong>About Toll Brothers</strong></p> <p align=\"left\"><a href=\"https://www.globenewswire.com/Tracker?data=wFuRYmEQtOiiaXDR6PxGfJPbH1pHBfLHTIUSo6raUZIlzbe4n72IcUhWKos3RRP0XfhJeEs6wLjloiNxvtPrb3piH4hkIv9UGlL6T1QrB3A=\" rel=\"nofollow noopener\" target=\"_blank\">Toll Brothers, Inc.</a>, a Fortune 500 Company, is the nation’s leading builder of luxury homes. The Company was founded in 1967 and became a public company in 1986 with common stock listed on the New York Stock Exchange under the symbol “TOL.” Toll Brothers builds new homes and communities in over 60 markets across the United States, serving first-time, move-up, active-adult, and second-home buyers. The Company also operates its own architectural, engineering, mortgage, title, land development, smart home technology, landscape, and building components manufacturing businesses.</p> <p align=\"left\">Toll Brothers was named the #1 Most Admired Home Builder in Fortune magazine’s 2026 list of the World’s Most Admired Companies®, the ninth year the Company has achieved this honor. Toll Brothers has also been named Builder of the Year by Builder magazine and is the first two-time recipient of Builder of the Year from Professional Builder magazine. For more information visit <a href=\"https://www.globenewswire.com/Tracker?data=ouEVesVyAswLAI9Td8vCgcUJGS7qLskyB3L_-Wg6cDntFMjeo2VS0Pku7Y-fCbls4VQWXT36JiiJlOiuuaDnWUmBuO9A0w5Dz_rfEBnPYbQ=\" rel=\"nofollow noopener\" target=\"_blank\">TollBrothers.com</a>.</p> <p align=\"left\">From Fortune, ©2026 Fortune Media IP Limited. All rights reserved. Used under license.</p> <p align=\"left\">Contact: Andrea Meck | Toll Brothers, Senior Director, Public Relations &amp; Social Media | 215-938-8169 | <a href=\"https://www.globenewswire.com/Tracker?data=RjQQA_ATzd3q5KlY12J3mRjHvUWhEijt4xc10U0-UYKEjAG1zPOBnTn3h5z3Tg3pmVEPq6BGFPjaKWhzx3LgDqZ_HN-smeKd6Vm_EZWsJAY=\" rel=\"nofollow noopener\" target=\"_blank\">ameck@tollbrothers.com</a></p> <p align=\"left\">Photos accompanying this announcement are available at:</p> <p align=\"left\"><a href=\"https://www.globenewswire.com/Tracker?data=iSjNrPrG69YBWvc8g1Rny5X4MeibPcQgNNgQA6kC6ksQFWG8FMy2Vo9_-ejAw2nxx5ytbRZkBXGAVG9So9LKSdLFnXLid2UW9B2AwKrJyNWyrQW8R2vbwLjcuxHEelIu9AXulZfwRh1mWGA_tKEX3chzRV_9uOZcrnJhIL3_u9LJyV_3qb_F1N2sNjxo3jJPIDo2Pqi446XfhJn0L43FXW49q1VLSPJxMBbBhynpjJOn-wbTsy-Qy21oVMVLO0kYgLRUR7_vgoRUT3Dmq1FX0A==\" rel=\"nofollow noopener\" target=\"_blank\">https://www.globenewswire.com/NewsRoom/AttachmentNg/7114915d-1253-4e65-9854-788750d0bbc0</a></p> <p><a href=\"https://www.globenewswire.com/Tracker?data=iSjNrPrG69YBWvc8g1Rny5X4MeibPcQgNNgQA6kC6ksQFWG8FMy2Vo9_-ejAw2nxt5QbVvgvhYX19oYn71Uz0j3N_Fj3SOM81pkrp2cUN5NxJ0FOJAc_H3mYZjYHjBfQdA2cjThtaKxaPQBTgem89Tg9bh7P4jjg_RYdaqe99t_m1WGKG-e2Rugo6hjq9J3IXf8FSnC_g4V_dqYYZFtWdkhVIJ4QUKkMzDcf-wgoU0BsemRofsmjSbAtF41SvDfljnGI4HPiXBHPt8Z3SH02Tw==\" rel=\"nofollow noopener\" target=\"_blank\">https://www.globenewswire.com/NewsRoom/AttachmentNg/b6701153-1ad6-4f85-aeca-0e217bf91fe8</a></p> <p><a href=\"https://www.globenewswire.com/Tracker?data=iSjNrPrG69YBWvc8g1Rny5X4MeibPcQgNNgQA6kC6ksQFWG8FMy2Vo9_-ejAw2nxFWdOy_BZp1Pwqhxt_xJDQvkPpzW1oChybo2z-WD4v_Tr3Jz1WsBzKAyHVvtLH2aRYCIKK-nHo7Oz-HYDkWnXHV8lAEci9BQyEAfxPQaZix9xNRtqSpLTsDweDV5y3x_HCNVj7r0cINOTKTAY6P6o4Q5ayN_Szgb6jyE0XSqlUZ5PlRUYOF4pc0A_tuPVJbY4zTVMdn3wpRGndeRUQFdhQw==\" rel=\"nofollow noopener\" target=\"_blank\">https://www.globenewswire.com/NewsRoom/AttachmentNg/3a6d5491-2423-4e8f-af31-f3f867ff0757</a></p> <p align=\"left\">Sent by Toll Brothers via Regional Globe Newswire (TOLL-REG)</p> <img alt=\"\" class=\"__GNW8366DE3E__IMG\" loading=\"lazy\" src=\"https://www.globenewswire.com/newsroom/ti?nf=OTY2MjQwNyM3NDU3NzU0IzIwMDc4NTM=\"/> <br/><img alt=\"\" loading=\"lazy\" referrerpolicy=\"no-referrer-when-downgrade\" src=\"https://ml.globenewswire.com/media/NTEyOGI3MDUtZDA3ZS00Y2M1LTg5ZDItN2U0NjI1NzViZDI2LTEwMTk0MjYtMjAyNi0wMi0yNi1lbg==/tiny/Toll-Brothers-Inc-.png\"/></article>",
            "link": "https://www.stocktitan.net/news/TOL/toll-brothers-at-everly-new-luxury-home-community-coming-soon-to-vf7q46qht7mv.html",
            "author": "stocktitan",
            "pub_date": "Thu, 26 Feb 2026 19:50:00 GMT",
            "source": "stocktitan",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Popular, Inc. Declares a Cash Dividend of $0.75 per Common Share | BPOP Stock News",
            "description": "<article class=\"article\"><p> <location idsrc=\"xmltag.org\" value=\"LU/us.pr.sanjun\">SAN JUAN, Puerto Rico</location>--(BUSINESS WIRE)--Popular, Inc. (NASDAQ: <a class=\"symbol-link\" href=\"/overview/BPOP/\" title=\"View BPOP stock overview\">BPOP</a>) announced today that its Board of Directors has approved a quarterly cash dividend of <money><money>$0.75</money></money> per share on its outstanding common stock. The dividend will be payable on April 1, 2026 to shareholders of record at the close of business on March 18, 2026.</p><p><b>About Popular, Inc.</b></p><p>Popular, Inc. (NASDAQ: <a class=\"symbol-link\" href=\"/overview/BPOP/\" title=\"View BPOP stock overview\">BPOP</a>) is the leading financial institution by both assets and deposits in <location idsrc=\"xmltag.org\" value=\"LC/pr\">Puerto Rico</location> and ranks among the top 50 U.S. bank holding companies by assets. Founded in 1893, Banco Popular de <location idsrc=\"xmltag.org\" value=\"LC/pr\">Puerto Rico</location>, Popular’s principal subsidiary, provides retail, mortgage and commercial banking services in <location idsrc=\"xmltag.org\" value=\"LC/pr\">Puerto Rico</location> and the <location idsrc=\"xmltag.org\" value=\"LC/us\">U.S.</location> and <location idsrc=\"xmltag.org\" value=\"LC/vg\">British Virgin Islands</location>, as well as auto and equipment leasing and financing in <location idsrc=\"xmltag.org\" value=\"LC/pr\">Puerto Rico</location>. Popular also offers broker-dealer and insurance services in <location idsrc=\"xmltag.org\" value=\"LC/pr\">Puerto Rico</location> through specialized subsidiaries. In the mainland <location idsrc=\"xmltag.org\" value=\"LC/us\">United States</location>, Popular provides retail and commercial banking services through its <location idsrc=\"xmltag.org\" value=\"LU/us.ny.nyc\">New York</location>-chartered banking subsidiary, Popular Bank, which has branches located in <location idsrc=\"xmltag.org\" value=\"LU/us.ny.nyc\">New York</location>, <location idsrc=\"xmltag.org\" value=\"LS/us.nj\">New Jersey</location> and <location idsrc=\"xmltag.org\" value=\"LS/us.fl\">Florida</location>.</p><p>Financial (English): P-EN-FIN</p><p><img alt=\"\" loading=\"lazy\" src=\"https://cts.businesswire.com/ct/CT?id=bwnews&amp;sty=20260225593127r1&amp;sid=acqr8&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\"/><span class=\"bwct31415\"></span></p><p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: </span><span id=\"mmgallerylink-link\"><a href=\"https://www.businesswire.com/news/home/20260225593127/en/\" rel=\"nofollow noopener\">https://www.businesswire.com/news/home/20260225593127/en/</a></span></p><p>Popular, Inc.<br/>Investor Relations:<br/>Paul J. Cardillo, 212-417-6721<br/>Senior Vice President and Investor Relations Officer<br/><a href=\"mailto:pcardillo@popular.com\" rel=\"nofollow noopener\" shape=\"rect\">pcardillo@popular.com</a></p><p>or</p><p>Media Relations:<br/>MC González Noguera, 917-804-5253<br/>Executive Vice President and Chief Communications &amp; Public Affairs Officer<br/><a href=\"mailto:mc.gonzalez@popular.com\" rel=\"nofollow noopener\" shape=\"rect\">mc.gonzalez@popular.com</a></p><p>Source: Popular, Inc.</p></article>",
            "link": "https://www.stocktitan.net/news/BPOP/popular-inc-declares-a-cash-dividend-of-0-75-per-common-fo7w539huz4w.html",
            "author": "stocktitan",
            "pub_date": "Thu, 26 Feb 2026 17:44:00 GMT",
            "source": "stocktitan",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Minaurum Accelerates Exploration at Alamos Silver Project; Expands to Six Drill Rigs and Reports Additional Results | MMRGF Stock News",
            "description": "<article class=\"article\"><p>Vancouver, British Columbia--(Newsfile Corp. - February 26, 2026) - <b>Minaurum Silver Inc. (TSXV: MGG) (OTCQX: <a class=\"symbol-link\" href=\"/overview/MMRGF/\" title=\"View MMRGF stock overview\">MMRGF</a>) (FSE: 78M0) (\"Minaurum\" or the \"Company\")</b> is pleased to report that <b>six drill rigs</b> are now operating at its <b>Alamos Silver Project</b> as part of the <b>Phase II - 50,000-metre resource expansion drill program</b>.  Minaurum will continue step-out drilling on vein zones with established resources at <b>Europa</b> and <b>Promontorio-Travesia</b>, while initiating resource-definition drilling on several additional veins, including <b>San Jose</b>, <b>Quintera, Cotera-Pulpito</b>, and <b>Minas Nuevas</b>.</p><p>Recent step-out drilling at Europa has returned multiple high-grade silver intercepts, including: <b>0.50 m of 524 g/t silver equivalent (\"AgEq\")</b> in hole AL25-172, <b>0.30 m of 1,032 g/t AgEq</b> in hole AL25-174 and <b>1.40 m of 290 g/t AgEq</b> in hole AL25-175.  At Travesía-Quintera, step-out drilling returned <b>2.55 m of 197 g/t AgEq</b>, including <b>0.40 m grading 567 g/t AgEq</b> in hole AL25-173 (see Table 1).</p><p><b>\"With the continued success of our step-out drilling at the Europa vein zone, we are pleased to have expanded our drill fleet from four to six rigs,\" </b>stated Darrell Rader, President and CEO of Minaurum Silver.<b> \"Supported by an inferred resource of 55 million ounces AgEq at Alamos and a fully funded 50,000-metre resource expansion program currently underway, Minaurum is well positioned to deliver an updated mineral resource estimate in the second half of 2026.  We anticipate a steady increase in drill results as the expanded fleet advances the program.\"</b></p><p>Mineralization at the Europa and Travesia-Quintera zones has intersected high-grade silver over narrower widths that clearly define the margins of the robust silver shoots.  The vein system displays a well-developed pinch-and-swell geometry along strike and down-dip, characterized by variations in vein thickness and grade.  This continuity is exemplified by Hole AL25-163 at Europa, which returned 12.35 metres grading 408 g/t AgEq, including 3.20 metres of 1,277 g/t AgEq, in a 250-metre step-out (see Minaurum news release dated February 10, 2026), demonstrating a potentially large expansion of the mineralized envelope.</p><p>At Quintera, drilling continues to intersect mineralization within and surrounding historic underground workings, as well as in parallel hanging-wall veins and along strike.  </p><p style=\"text-align: center;\"><a href=\"https://images.newsfilecorp.com/files/3455/285489_8c7cd3810420b91b_003full.jpg\" rel=\"nofollow noopener\"><img alt=\"Cannot view this image? Visit: https://images.newsfilecorp.com/files/3455/285489_8c7cd3810420b91b_003.jpg\" loading=\"lazy\" src=\"https://images.newsfilecorp.com/files/3455/285489_8c7cd3810420b91b_003.jpg\" style=\"border-width: 0px;\"/></a><br/><br/><b>Figure 1. </b>Plan view showing locations of Travesía, Quintera, Promontorio, and Europa vein zones, showing areas of the current resource estimate and areas to be drilled in 2026 to expand the resource. Click to enlarge.</p><p style=\"text-align: center;\">To view an enhanced version of this graphic, please visit:<br/><a href=\"https://images.newsfilecorp.com/files/3455/285489_8c7cd3810420b91b_003full.jpg\" rel=\"nofollow noopener\">https://images.newsfilecorp.com/files/3455/285489_8c7cd3810420b91b_003full.jpg</a></p><p style=\"text-align: center;\"><a href=\"https://images.newsfilecorp.com/files/3455/285489_8c7cd3810420b91b_004full.jpg\" rel=\"nofollow noopener\"><img alt=\"Cannot view this image? Visit: https://images.newsfilecorp.com/files/3455/285489_8c7cd3810420b91b_004.jpg\" loading=\"lazy\" src=\"https://images.newsfilecorp.com/files/3455/285489_8c7cd3810420b91b_004.jpg\" style=\"border-width: 0px;\"/></a><br/><br/><b>Figure 2. </b>Longitudinal section of Europa vein zone, showing locations of highlighted mineralized intersections. Click to enlarge.</p><p style=\"text-align: center;\">To view an enhanced version of this graphic, please visit:<br/><a href=\"https://images.newsfilecorp.com/files/3455/285489_8c7cd3810420b91b_004full.jpg\" rel=\"nofollow noopener\">https://images.newsfilecorp.com/files/3455/285489_8c7cd3810420b91b_004full.jpg</a></p><p style=\"text-align: center;\"><a href=\"https://images.newsfilecorp.com/files/3455/285489_8c7cd3810420b91b_005full.jpg\" rel=\"nofollow noopener\"><img alt=\"Cannot view this image? Visit: https://images.newsfilecorp.com/files/3455/285489_8c7cd3810420b91b_005.jpg\" loading=\"lazy\" src=\"https://images.newsfilecorp.com/files/3455/285489_8c7cd3810420b91b_005.jpg\" style=\"border-width: 0px;\"/></a><br/><br/><b>Figure 3. </b>Cross sections of Europa and Nueva Europa vein zones, showing holes AL25-172 and AL25-174. EV=volcanic rocks, CZ=marble and skarn, GR=granodiorite. Click to enlarge.</p><p style=\"text-align: center;\">To view an enhanced version of this graphic, please visit:<br/><a href=\"https://images.newsfilecorp.com/files/3455/285489_8c7cd3810420b91b_005full.jpg\" rel=\"nofollow noopener\">https://images.newsfilecorp.com/files/3455/285489_8c7cd3810420b91b_005full.jpg</a></p><p><b>Table 1</b>.  Assay highlights of drill holes AL25-168 through AL25-178, Alamos project<i>.   </i> </p><p style=\"text-align: center;\"><b>EUROPA</b></p><table border=\"0\" cellpadding=\"3\" cellspacing=\"0\" style=\"width: 100%; border-collapse: collapse; border-width: 1px; border-style: solid; border-\"><tbody><tr><td style=\"border-width: 2px 1px 2px 2px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\"><b>Hole</b></td><td style=\"border-width: 2px 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\"><b>From <br/>(m)</b></td><td style=\"border-width: 2px 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\"><b>To </b><br/><b>(m)</b></td><td style=\"border-width: 2px 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\"><b>Interval <br/>(m)</b></td><td style=\"border-width: 2px 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\"><b>Est. True width (m)</b></td><td style=\"border-width: 2px 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\"><b>Ag </b><br/><b>g/t</b></td><td style=\"border-width: 2px 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\"><b>Au <br/>g/t</b></td><td style=\"border-width: 2px 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\"><b>Cu <br/>%</b></td><td style=\"border-width: 2px 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\"><b>Pb <br/>%</b></td><td style=\"border-width: 2px 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\"><b>Zn <br/>%</b></td><td style=\"border-width: 2px 2px 2px 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\"><b>AgEq <br/>g/t</b></td></tr><tr><td style=\"border-width: 1px 1px 1px 2px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\"><b>AL25-168</b></td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">18.35</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">18.85</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.50</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.40</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">45.6</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.015</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.01</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.011</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.055</td><td style=\"border-width: 1px 2px 1px 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">49</td></tr><tr><td style=\"border-width: 1px 1px 1px 2px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\"><b>AL25-171</b></td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">387.35</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">387.90</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.55</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.50</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">74.8</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.008</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.099</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.104</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.222</td><td style=\"border-width: 1px 2px 1px 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">91</td></tr><tr><td rowspan=\"6\" style=\"border-width: 1px 1px 1px 2px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\"><b>AL25-172</b></td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">141.55</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">142.05</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.50</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.45</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\"><b>469</b></td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.093</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.25</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.434</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.695</td><td style=\"border-width: 1px 2px 1px 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\"><b>524</b></td></tr><tr><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">189.50</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">190.20</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.70</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.65</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">64.3</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.224</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.078</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">1.775</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\"><b>2.22</b></td><td style=\"border-width: 1px 2px 1px 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">179</td></tr><tr><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">233.55</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">234.45</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.90</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.80</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">124</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.004</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.433</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">1.31</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\"><b>5.43</b></td><td style=\"border-width: 1px 2px 1px 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\"><b>316</b></td></tr><tr><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">259.10</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">259.60</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.50</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.45</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">82.2</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.001</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.124</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.272</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.621</td><td style=\"border-width: 1px 2px 1px 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">113</td></tr><tr><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">267.00</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">267.50</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.50</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.45</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">54.9</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.011</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.542</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.055</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.065</td><td style=\"border-width: 1px 2px 1px 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">105</td></tr><tr><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">291.90</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">292.90</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">1.00</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.90</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">164</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.268</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.208</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.773</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">1.483</td><td style=\"border-width: 1px 2px 1px 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\"><b>256</b></td></tr><tr><td rowspan=\"6\" style=\"border-width: 1px 1px 1px 2px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\"><b>AL25-174</b></td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">220.35</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">220.90</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.55</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.45</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">93.1</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.01</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.295</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.448</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.999</td><td style=\"border-width: 1px 2px 1px 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">152</td></tr><tr><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">362.85</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">363.20</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.35</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.30</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">23.5</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.012</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.085</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.167</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\"><b>3.57</b></td><td style=\"border-width: 1px 2px 1px 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">120</td></tr><tr><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">364.15</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">365.50</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">1.35</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">1.10</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\"><b>218.8</b></td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.004</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.075</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.547</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">1.21</td><td style=\"border-width: 1px 2px 1px 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\"><b>265</b></td></tr><tr><td colspan=\"10\" style=\"border-width: 1px 2px 1px 1px; border-style: solid; border- text-align: center; vertical-align: middle; font-size: 10px;\"><i>including</i></td></tr><tr><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">365.20</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">365.50</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.30</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.25</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\"><b>936</b></td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.159</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.218</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">1.09</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">1.765</td><td style=\"border-width: 1px 2px 1px 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\"><b>1032</b></td></tr><tr><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">366.90</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">367.35</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.45</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.35</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">89</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.114</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.116</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\"><b>2.58</b></td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">1.815</td><td style=\"border-width: 1px 2px 1px 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\"><b>204</b></td></tr><tr><td rowspan=\"4\" style=\"border-width: 1px 1px 1px 2px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\"><b>AL25-175</b></td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">134.20</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">136.35</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">2.15</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">1.85</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">77</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.016</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.02</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.115</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.538</td><td style=\"border-width: 1px 2px 1px 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">95</td></tr><tr><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">467.05</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">470.85</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">3.80</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">3.20</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">139</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.021</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.474</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.209</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.427</td><td style=\"border-width: 1px 2px 1px 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\"><b>195</b></td></tr><tr><td colspan=\"10\" style=\"border-width: 1px 2px 1px 1px; border-style: solid; border- text-align: center; vertical-align: middle; font-size: 10px;\"><i>including</i></td></tr><tr><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">468.40</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">469.80</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">1.40</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">1.15</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\"><b>226</b></td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.015</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.557</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.2</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.472</td><td style=\"border-width: 1px 2px 1px 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\"><b>290</b></td></tr><tr><td rowspan=\"2\" style=\"border-width: 1px 1px 2px 2px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\"><b>AL25-177</b></td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">220.85</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">221.35</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.50</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.35</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">27.5</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.088</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.265</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">1.465</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">1.65</td><td style=\"border-width: 1px 2px 1px 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">126</td></tr><tr><td style=\"border-width: 1px 1px 2px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">241.95</td><td style=\"border-width: 1px 1px 2px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">242.65</td><td style=\"border-width: 1px 1px 2px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.70</td><td style=\"border-width: 1px 1px 2px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.50</td><td style=\"border-width: 1px 1px 2px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">75.4</td><td style=\"border-width: 1px 1px 2px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.103</td><td style=\"border-width: 1px 1px 2px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.376</td><td style=\"border-width: 1px 1px 2px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.136</td><td style=\"border-width: 1px 1px 2px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.651</td><td style=\"border-width: 1px 2px 2px 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">135</td></tr></tbody></table><p> </p><p style=\"text-align: center;\"><b>QUINTERA-TRAVESIA</b></p><table border=\"0\" cellpadding=\"3\" cellspacing=\"0\" style=\"width: 100%; border-collapse: collapse; border-width: 1px; border-style: solid; border-\"><tbody><tr><td style=\"border-width: 2px 1px 2px 2px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\"><b>Hole</b></td><td style=\"border-width: 2px 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\"><b>From <br/>(m)</b></td><td style=\"border-width: 2px 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\"><b>To </b><br/><b>(m)</b></td><td style=\"border-width: 2px 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\"><b>Interval <br/>(m)</b></td><td style=\"border-width: 2px 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\"><b>Est. True width (m)</b></td><td style=\"border-width: 2px 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\"><b>Ag </b><br/><b>g/t</b></td><td style=\"border-width: 2px 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\"><b>Au <br/>g/t</b></td><td style=\"border-width: 2px 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\"><b>Cu <br/>%</b></td><td style=\"border-width: 2px 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\"><b>Pb <br/>%</b></td><td style=\"border-width: 2px 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\"><b>Zn <br/>%</b></td><td style=\"border-width: 2px 2px 2px 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\"><b>AgEq <br/>g/t</b></td></tr><tr><td style=\"border-width: 1px 1px 1px 2px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\"><b>AL25-169</b></td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">311.10</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">311.40</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.30</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.25</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">4.8</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.004</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.001</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.557</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\"><b>2.51</b></td><td style=\"border-width: 1px 2px 1px 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">76</td></tr><tr><td style=\"border-width: 1px 1px 1px 2px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\"><b>AL25-170</b></td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">188.90</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">190.25</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">1.35</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">1.15</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">81</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.018</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.191</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.186</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.221</td><td style=\"border-width: 1px 2px 1px 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">108</td></tr><tr><td rowspan=\"3\" style=\"border-width: 1px 1px 1px 2px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\"><b>AL25-173</b></td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">309.45</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">312.00</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">2.55</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">2.20</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">170</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.036</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.2</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.16</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.171</td><td style=\"border-width: 1px 2px 1px 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\"><b>197</b></td></tr><tr><td colspan=\"10\" style=\"border-width: 1px 2px 1px 1px; border-style: solid; border- text-align: center; vertical-align: middle; font-size: 10px;\"><i>including</i></td></tr><tr><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">309.45</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">309.85</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.40</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.35</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\"><b>507</b></td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.061</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.607</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.107</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.045</td><td style=\"border-width: 1px 2px 1px 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\"><b>567</b></td></tr><tr><td style=\"border-width: 1px 1px 1px 2px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\"><b>AL25-176</b></td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">46.05</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">46.45</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.40</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.35</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">22.9</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.003</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.131</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.611</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\"><b>2.17</b></td><td style=\"border-width: 1px 2px 1px 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">98</td></tr><tr><td rowspan=\"3\" style=\"border-width: 1px 1px 2px 2px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\"><b>AL25-178</b></td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">39.90</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">40.40</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.50</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.45</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">72.8</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.006</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.187</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.093</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.251</td><td style=\"border-width: 1px 2px 1px 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">97</td></tr><tr><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">137.30</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">138.15</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.85</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.70</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">171</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.015</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.418</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">1.4</td><td style=\"border-width: 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.583</td><td style=\"border-width: 1px 2px 1px 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\"><b>250</b></td></tr><tr><td style=\"border-width: 1px 1px 2px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">169.70</td><td style=\"border-width: 1px 1px 2px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">170.45</td><td style=\"border-width: 1px 1px 2px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.75</td><td style=\"border-width: 1px 1px 2px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.65</td><td style=\"border-width: 1px 1px 2px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\"><b>311</b></td><td style=\"border-width: 1px 1px 2px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.026</td><td style=\"border-width: 1px 1px 2px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.676</td><td style=\"border-width: 1px 1px 2px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.912</td><td style=\"border-width: 1px 1px 2px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\">0.525</td><td style=\"border-width: 1px 2px 2px 1px; border-style: solid; border- width: 9.1%; text-align: center; vertical-align: middle; font-size: 10px;\"><b>401</b></td></tr></tbody></table><p> </p><p>Estimated true widths are based on current interpretation of mineralized structures.<br/>Weight-averaged silver-equivalent grades (AgEq g/t) are based on: </p><ul style=\"list-style-type: disc;\"><li>October 1, 2025 Long-term CIBC Global Mining Group Analyst Consensus Commodity Price Forecast: Ag <money>$29.73</money>/tr oz, Au <money>$2,646</money>/tr oz, Cu <money>$4.34</money>/lb, Pb <money>$0.92</money>/lb, Zn <money>$1.21</money>/lb.  </li><li>Metallurgical recovery assumption: <percent>88.3%</percent> for Ag, <percent>88.5%</percent> for Au, <percent>75.5%</percent> for Cu, <percent>83%</percent> for Pb, <percent>75%</percent> for Zn.  </li></ul><p style=\"text-align: center;\"><a href=\"https://images.newsfilecorp.com/files/3455/285489_8c7cd3810420b91b_006full.jpg\" rel=\"nofollow noopener\"><img alt=\"Cannot view this image? Visit: https://images.newsfilecorp.com/files/3455/285489_8c7cd3810420b91b_006.jpg\" loading=\"lazy\" src=\"https://images.newsfilecorp.com/files/3455/285489_8c7cd3810420b91b_006.jpg\" style=\"border-width: 0px;\"/></a><br/><br/><b>Figure 4</b>. Longitudinal section of Travesia-Promontorio vein zones, showing locations of highlighted mineralized intersections. Click to enlarge.</p><p style=\"text-align: center;\">To view an enhanced version of this graphic, please visit:<br/><a href=\"https://images.newsfilecorp.com/files/3455/285489_8c7cd3810420b91b_006full.jpg\" rel=\"nofollow noopener\">https://images.newsfilecorp.com/files/3455/285489_8c7cd3810420b91b_006full.jpg</a></p><p><b>Follow us and stay updated:</b></p><p>YouTube: <a href=\"https://api.newsfilecorp.com/redirect/4YBmLtQbN1\" rel=\"nofollow noopener\">@MinaurumSilver</a><br/>X: <a href=\"https://api.newsfilecorp.com/redirect/jNYgAFOow0\" rel=\"nofollow noopener\">@MinaurumSilver</a><br/>LinkedIn: <a href=\"https://api.newsfilecorp.com/redirect/vEzMZIoEVL\" rel=\"nofollow noopener\">Minaurum Silver Inc</a><br/>Facebook: <a href=\"https://api.newsfilecorp.com/redirect/JkYB1C7G0o\" rel=\"nofollow noopener\">Minaurum Silver Inc.</a><br/>Subscribe to our email list at <a href=\"https://api.newsfilecorp.com/redirect/GzqQZF07GO\" rel=\"nofollow noopener\">www.minaurum.com</a></p><p><b>Minaurum Silver Inc. (TSXV: MGG) (OTCQX: MMRGF) (FSE: 78M0)</b> is an Americas-focused explorer concentrating on the high-grade <percent>100%</percent> owned, production-permitted Alamos silver project in southern Sonora, Mexico and the Lone Mountain CRD Project in Nevada, USA. Minaurum is managed by one of the strongest technical and finance teams and will continue its founders' legacy of creating shareholder value by acquiring and developing a pipeline of Tier-One precious-and base metal projects.</p><div id=\"contactInfo\"><p>ON BEHALF OF THE BOARD</p><p>\"<i>Darrell A. Rader</i>\"</p><p>Darrell A. Rader</p><p>President and CEO</p><p>For more information, please contact:<br/>Sunny Pannu - Investor Relations and Corporate Development Manager<br/>(778) 330 0994 or via email at <a href=\"mailto:pannu@minaurum.com\" rel=\"nofollow noopener\">pannu@minaurum.com</a> </p></div><p>The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this news release.</p><p>_________________________________________________________________________</p><p>1570- 200 Burrard Street <br/>Telephone: 1 778 330-0994<br/>Vancouver, BC V6C 3L6 <br/><a href=\"https://api.newsfilecorp.com/redirect/Q2pXniEYmZ\" rel=\"nofollow noopener\">www.minaurum.com</a> <br/> <a href=\"mailto:info@minaurum.com\" rel=\"nofollow noopener\">info@minaurum.com</a><u> </u></p><p><i><font style=\"font-size: 11px;\"><b>Data review and verification:</b> Stephen R. Maynard, Vice President of Exploration of Minaurum and a Qualified Person (QP) as defined by National Instrument 43-101, reviewed and verified the assay data, and has approved the disclosure in this news release. Verification was done by visual inspection of core samples and comparison to assay results. Assay results have not been checked by re-analysis. No factors were identified that could materially affect the accuracy or reliability of the data presented in this news release.</font></i></p><p><i><font style=\"font-size: 11px;\"><b>Analytical Procedures and Quality Assurance/Quality Control: </b>Preparation and assaying of drilling samples from Minaurum's Alamos project are done with strict adherence to a Quality Assurance/Quality Control (QA/QC) protocol. Core samples are sawed in half and then bagged in a secure facility near the site and then shipped either by a licensed courior by Company personnel to ALS Minerals' preparation facility in Hermosillo, Sonora, Mexico. ALS prepares the samples, crushing them to <percent>70%</percent> less than 2mm, splitting off 250g, and pulverizing the split to more than <percent>85%</percent> passing 75 microns. The resulting sample pulps are prepared in Hermosillo and then shipped to Vancouver for chemical analysis by ALS Minerals. In Vancouver, the pulps are analyzed for gold by fire assay and ICP/AES on a 30-gram charge. In addition, analyses are done for silver, copper, lead, and zinc using 4-acid digestion and ICP analysis. Samples with silver values greater than 100 g/t; and copper, lead, or zinc values greater than 10,000 ppm (<percent>1%</percent>) are re-analyzed using 4-acid digestion and atomic absorption spectrometry (AAS). </font></i></p><p><i><font style=\"font-size: 11px;\">Quality-control (QC) samples are inserted in the sample stream every 20 samples on average, and thus represent <percent>5%</percent> of the total samples. QC samples include standards, blanks, and duplicate samples. Standards are pulps that have been prepared by a third-party laboratory; they have gold, silver, and base-metal values that are established by an extensive analytical process in which several commercial labs (including ALS Minerals) participate. Standards test the calibration of the analytical equipment. Blanks are rock material known from prior sampling to contain less than 0.005 ppm gold; they test the sample preparation procedure for cross-sample contamination.  In the case of duplicates, the sample interval is cut in half and then quartered. The first quarter is the original sample, the second becomes the duplicate. Duplicate samples provide a test of the reproducibility of assays in the same drilled interval. When final assays are received, QC sample results are inspected for deviation from accepted values. To date, QC sample analytical results have fallen in acceptable ranges on the Alamos project.</font></i></p><p><i><font style=\"font-size: 11px;\">When final assays are received, QC sample results are inspected for deviation from accepted values by the QP. To date, QC sample analytical results have fallen in acceptable ranges on the Alamos project.</font></i></p><p><i><font style=\"font-size: 11px;\">ALS Minerals is independent of Minaurum Silver and is independent of the Qualified Person.</font></i></p><p><i><font style=\"font-size: 11px;\"><b>Cautionary Note Regarding Forward-Looking Information: </b>This news release contains \"forward-looking information\" within the meaning of applicable Canadian securities legislation. \"Forward-looking information\" includes, but is not limited to, statements with respect to the activities, events or developments that the Company expects or anticipates will or may occur in the future, including the Resource Estimate; the ongoing Phase II 50,000 m resource expansion drill program; and the completion of an updated resource estimate in the second half of 2026. Generally, but not always, forward-looking information and statements can be identified by the use of words such as \"plans\", \"expects\", \"is expected\", \"budget\", \"scheduled\", \"estimates\", \"forecasts\", \"intends\", \"anticipates\", or \"believes\" or the negative connotation thereof or variations of such words and phrases or state that certain actions, events or results \"may\", \"could\", \"would\", \"might\" or \"will be taken\", \"occur\" or \"be achieved\" or the negative connotation thereof.</font></i></p><p><i><font style=\"font-size: 11px;\">In making the forward-looking information in this release, Minaurum has applied certain factors and assumptions that are based on Minaurum's current beliefs as well as assumptions made by and information currently available to Minaurum, including that Minaurum will be able to obtain all necessary permits and approvals for planned exploration and drilling activities; that Minaurum's planned drilling and exploration activities will be completed on the expected timeline, or at all; that the results of the drilling and exploration activities will be as expected; that Minaurum will be able to complete the updated mineral resource estimate on the timelines expected, or at all; and that Minaurum will have the financial resources to complete its ongoing drill program and anticipated updated mineral resource estimate. Although Minaurum considers these assumptions to be reasonable based on information currently available to it, they may prove to be incorrect, and the forward-looking information in this release are subject to numerous risks, uncertainties and other factors that may cause future results to differ materially from those expressed or implied in such forward-looking information.  </font></i></p><p><i><font style=\"font-size: 11px;\">In making the forward-looking information in this release, Minaurum has applied certain factors and assumptions that are based on Minaurum's current beliefs as well as assumptions made by and information currently available to Minaurum. Although Minaurum considers these assumptions to be reasonable based on information currently available to it, they may prove to be incorrect, and the forward-looking information in this release are subject to numerous risks, uncertainties and other factors that may cause future results to differ materially from those expressed or implied in such forward-looking information, including risks relating to the actual results of drilling or exploration activities, fluctuating silver prices, possibility of equipment breakdowns and delays, drilling or exploration cost overruns, availability of capital and financing, general economic, market or business conditions, regulatory changes and timeliness of government or regulatory approvals.  </font></i></p><p><i><font style=\"font-size: 11px;\">Readers are cautioned not to place undue reliance on forward-looking information. Minaurum does not intend, and expressly disclaims any intention or obligation to, update or revise any forward-looking information whether as a result of new information, future events or otherwise, except as required by law.</font></i></p><p id=\"corporateNewsLogoContainer\"><img alt=\"Corporate Logo\" id=\"corporateNewsLogo\" loading=\"lazy\" src=\"https://images.newsfilecorp.com/files/3455/285489_8c7cd3810420b91b_logo.jpg\"/></p><p id=\"corporateLinkBack\">To view the source version of this press release, please visit <a href=\"https://api.newsfilecorp.com/redirect/mjxEAHxX3J\" rel=\"nofollow noopener\">https://www.newsfilecorp.com/release/285489</a></p><p><img alt=\"\" loading=\"lazy\" src=\"https://api.newsfilecorp.com/newsinfo/285489/375\"/></p></article>",
            "link": "https://www.stocktitan.net/news/MMRGF/minaurum-accelerates-exploration-at-alamos-silver-project-expands-to-9dqi6r9iu1k1.html",
            "author": "stocktitan",
            "pub_date": "Thu, 26 Feb 2026 17:50:00 GMT",
            "source": "stocktitan",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Early study results from Johnson & Johnson show promising antitumor activity with combination of pasritamig and docetaxel in advanced prostate cancer | JNJ Stock News",
            "description": "<article class=\"article\"><div class=\"xn-content\"><p><i>Combination demonstrates deep PSA responses and favorable safety profile with plans to advance into Phase 3</i></p><p><i>Data highlight the potential of this first-in-class next-generation T-cell engager to expand the role of immunotherapy in prostate cancer</i></p><p><span class=\"legendSpanClass\"><location idsrc=\"xmltag.org\" value=\"LU/us.nj.rartan\">RARITAN, N.J.</location></span>, <span class=\"legendSpanClass\">Feb. 26, 2026</span> /PRNewswire/ -- Johnson &amp; Johnson (NYSE:<a class=\"symbol-link\" href=\"/overview/JNJ/\" title=\"View JNJ stock overview\">JNJ</a>) today announced preliminary results from a Phase 1b study evaluating pasritamig (JNJ-78278343), a first-in-class bispecific T-cell engaging antibody, in combination with docetaxel in patients with metastatic castration-resistant prostate cancer. The combination demonstrated a safety profile consistent with docetaxel alone, with no new or unexpected safety signals observed. The regimen also showed clinically meaningful efficacy, including high rates of prostate-specific antigen (PSA) responses and sustained PSA reductions, supporting continued development and advancement into Phase 3 studies. The results were presented for the first time at the 2026 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium (Abstract #171).<sup>1</sup></p><div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\"><p><a href=\"https://mma.prnewswire.com/media/2333578/Johnson_and_Johnson_Logo_v1.html\" rel=\"nofollow noopener\" target=\"_blank\"><img alt=\"(PRNewsfoto/Johnson &amp; Johnson)\" loading=\"lazy\" src=\"https://mma.prnewswire.com/media/2333578/Johnson_and_Johnson_Logo_v1.jpg\" title=\"(PRNewsfoto/Johnson &amp; Johnson)\"/></a></p></div><p>Pasritamig is designed to engage the immune system through a novel mechanism of action, binding CD3 on T cells and human kallikrein 2 (KLK2). KLK2 is a novel, highly specific prostate cancer target with minimal expression outside prostate tissue. By both activating and directing T cells to KLK2-expressing tumor cells, pasritamig enables targeted immune engagement. This differentiated, prostate-specific approach was intentionally built to focus immune activity on prostate cancer cells, which may help limit effects on healthy tissue, and supports administration in a doctor's office rather than hospital setting.</p><p>\"These data represent an important step forward for patients with advanced prostate cancer,\" said Professor Shahneen Sandhu,* M.D., Ph.D., MBBS, FRACP, Associate Professor, Consultant Medical Oncologist and researcher at Peter MacCallum Cancer Centre, and study investigator. \"In a disease where outcomes remain poor for many patients, seeing encouraging clinical activity alongside a favorable safety profile in combination with docetaxel reinforces the potential of this approach and supports further clinical development.\"</p><p>\"Based on these findings, we are increasingly confident in the potential of pasritamig to meaningfully improve outcomes for people with prostate cancer,\" said Charles Drake, M.D., Ph.D., Vice President, Prostate Cancer and Cross Cancer Immuno-Oncology, Johnson &amp; Johnson. \"The ability to combine pasritamig with docetaxel, where prior approaches in the field have fallen short, gives us a strong foundation for Phase 3 development. What we're seeing with this combination, including deep and durable PSA responses, underscores the promise of this combination immunotherapy approach and our commitment to advancing innovation that can make a difference for patients.\"</p><p><b>Detailed Study Results</b></p><p>In the study, pasritamig was evaluated in combination with docetaxel in an outpatient setting in patients with metastatic castration-resistant prostate cancer whose disease had progressed following androgen receptor pathway inhibitor therapy. Approximately half of the patients (45 percent) had received at least one prior taxane-based regimen. The primary endpoint was safety and identification of the recommended regimen for further development in Phase 2/3 studies, with secondary and exploratory endpoints assessing clinical activity, including PSA response rates.<sup>1</sup></p><p>As of December 9, 2025, 51 patients had received pasritamig plus docetaxel, including patients who were pretreated with a median of three prior therapies (range, 1-9). Reductions of 50 percent or greater in PSA levels were achieved in 64.7 percent of patients overall and in 75.0 percent of taxane-naïve patients. Reductions of 90 percent or greater in PSA levels were achieved in 39.2 percent of patients overall and 53.6 percent of taxane-naïve patients. Among taxane-naïve patients with bone-only disease, confirmed PSA reductions of 50 percent or greater and 90 percent or greater were observed in 88.2 percent and 76.5 percent of patients, respectively. Patients were able to continue pasritamig beyond docetaxel discontinuation. Those patients received a median of six docetaxel doses every three weeks and eight pasritamig doses every six weeks, supporting the potential for sustained disease control over time.<sup>1</sup></p><p>The safety profile of pasritamig plus docetaxel was consistent with the known safety profile of docetaxel in metastatic castration-resistant prostate cancer. The most common treatment-related adverse events (TRAEs) occurring in at least 20 percent of patients included fatigue (60.8 percent), alopecia (41.2 percent), diarrhea and nausea (31.4 percent each), peripheral edema (27.5 percent), peripheral sensory neuropathy (25.5 percent) and dysgeusia (23.5 percent). Pasritamig-related adverse events occurring in at least 10 percent of patients were fatigue (33.3 percent) and non-chronic diarrhea (11.8 percent). Grade 3 or higher TRAEs attributed to docetaxel were observed in 29.4 percent of patients, compared with only two percent attributed to pasritamig. No patients experienced cytokine release syndrome of any grade or treatment-related deaths.<sup>1 </sup></p><p>Two ongoing Phase 3 studies are evaluating pasritamig in the metastatic castration-resistant prostate cancer setting. KLK2-comPAS (<a href=\"https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4625130-1&amp;h=3339634161&amp;u=https%3A%2F%2Fclinicaltrials.gov%2Fstudy%2FNCT07164443&amp;a=NCT07164443\" rel=\"nofollow noopener\" target=\"_blank\">NCT07164443</a>) is evaluating pasritamig as monotherapy, and KLK2-PASenger (<a href=\"https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4625130-1&amp;h=293832908&amp;u=https%3A%2F%2Fclinicaltrials.gov%2Fstudy%2FNCT07225946&amp;a=NCT07225946\" rel=\"nofollow noopener\" target=\"_blank\">NCT07225946</a>) is evaluating pasritamig in combination with docetaxel.<sup>2</sup><sup>,3</sup> Beyond these Phase 3 studies, pasritamig is also being evaluated in earlier-phase combination studies. Pasritamig monotherapy has received Breakthrough Therapy Designation in <location idsrc=\"xmltag.org\" value=\"LC/cn\">China</location> and Fast Track designation from the <location idsrc=\"xmltag.org\" value=\"LC/us\">U.S.</location> Food and Drug Administration, supporting its continued clinical development.</p><p><b>About the Study</b></p><p>The Phase 1b study (<a href=\"https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4625130-1&amp;h=150922530&amp;u=https%3A%2F%2Fwww.clinicaltrials.gov%2Fstudy%2FNCT05818683&amp;a=NCT05818683\" rel=\"nofollow noopener\" target=\"_blank\">NCT05818683</a>) is an open-label trial evaluating the safety and clinical activity of pasritamig in combination with docetaxel in patients with metastatic castration-resistant prostate cancer (mCRPC) whose disease has progressed following treatment with an androgen receptor pathway inhibitor. The primary objective is to determine the recommended regimen for further development based on safety, with secondary and exploratory endpoints assessing clinical activity. Pasritamig was administered intravenously every six weeks, with initial step-up doses given during the first treatment cycle, in combination with docetaxel administered intravenously every three weeks. Treatment was delivered in an outpatient setting. Corticosteroids were used only as standard premedication for docetaxel, and hematopoietic growth factor support was permitted as needed.<sup>4</sup></p><p><b>About Pasritamig (JNJ-78278343)</b></p><p>Pasritamig (JNJ-78278343) is an investigational T-cell-redirecting bispecific antibody (bsAb) targeting human kallikrein 2 (KLK2) on prostate cancer cells and CD3 receptor complexes on T cells, leveraging the body's immune system to selectively target and eliminate cancer cells. This innovative approach is being evaluated in pretreated patients with metastatic castration-resistant prostate cancer (mCRPC), a patient population with limited treatment options.</p><p><b>About Metastatic Castration-Resistant Prostate Cancer (mCRPC)</b></p><p>Metastatic castration-resistant prostate cancer (mCRPC) is a challenging and aggressive stage of prostate cancer where the disease progresses despite androgen deprivation therapy.<sup>5</sup> Patients often experience metastasis to bones and lymph nodes, leading to poor outcomes and limited treatment options, including chemotherapy and second-line hormone therapies.<sup>6</sup> The median overall survival ranges from 13.5 to 31.6 months depending on the site of metastasis, with a typical range of 15 to 36 months across the broader population.<sup>7,8</sup> Survival rates can vary significantly depending on factors such as prior treatment history, disease burden, and response to therapy. The need for more effective treatments is critical, as the disease continues to impact a large number of men globally, with metastatic castration-resistant prostate cancer (mCRPC) being responsible for a substantial number of prostate cancer-related deaths.</p><p><b>About Johnson &amp; Johnson</b></p><p>At Johnson &amp; Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow and profoundly impact health for humanity. Learn more at <a href=\"https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4625130-1&amp;h=3918609809&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4320026-1%26h%3D2519303370%26u%3Dhttps%253A%252F%252Fc212.net%252Fc%252Flink%252F%253Ft%253D0%2526l%253Den%2526o%253D4112868-1%2526h%253D4201296569%2526u%253Dhttps%25253A%25252F%25252Fwww.jnj.com%25252F%2526a%253Dhttps%25253A%25252F%25252Fwww.jnj.com%25252F%26a%3Dhttps%253A%252F%252Fwww.jnj.com%252F&amp;a=https%3A%2F%2Fwww.jnj.com%2F\" rel=\"nofollow noopener\" target=\"_blank\">https://www.jnj.com/</a> or at <a href=\"https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4625130-1&amp;h=2173397519&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4320026-1%26h%3D51411588%26u%3Dhttp%253A%252F%252Fwww.innovativemedicine.jnj.com%252F%26a%3Dwww.innovativemedicine.jnj.com&amp;a=www.innovativemedicine.jnj.com\" rel=\"nofollow noopener\" target=\"_blank\">www.innovativemedicine.jnj.com</a>. Follow us at <a href=\"https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4625130-1&amp;h=3652999725&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4320026-1%26h%3D2703097812%26u%3Dhttps%253A%252F%252Fc212.net%252Fc%252Flink%252F%253Ft%253D0%2526l%253Den%2526o%253D4112868-1%2526h%253D715685265%2526u%253Dhttps%25253A%25252F%25252Ftwitter.com%25252FJNJInnovMed%2526a%253D%252540JNJInnovMed%26a%3D%2540JNJInnovMed&amp;a=%40JNJInnovMed\" rel=\"nofollow noopener\" target=\"_blank\">@JNJInnovMed</a>.</p><p><b>Cautions Concerning Forward-Looking Statements</b></p><p><i>This press release contains \"forward-looking statements\" as defined in the Private Securities Litigation Reform Act of 1995 regarding product development and the potential benefits and treatment impact of pasritamig (JNJ-78278343). The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Johnson &amp; Johnson. Risks and uncertainties include, but are not limited to: challenges and uncertainties inherent in product research and development, including the uncertainty of clinical success and of obtaining regulatory approvals; uncertainty of commercial success; manufacturing difficulties and delays; competition, including technological advances, new products and patents attained by competitors; challenges to patents; product efficacy or safety concerns resulting in product recalls or regulatory action; changes in behavior and spending patterns of purchasers of health care products and services; changes to applicable laws and regulations, including global health care reforms; and trends toward health care cost containment. A further list and descriptions of these risks, uncertainties and other factors can be found in Johnson &amp; Johnson's most recent Annual Report on Form 10-K, including in the sections captioned \"Cautionary Note Regarding Forward-Looking Statements\" and \"Item 1A. Risk Factors,\" and in Johnson &amp; Johnson's subsequent Quarterly Reports on Form 10-Q and other filings with the Securities and Exchange Commission. Copies of these filings are available online at </i><a href=\"https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4625130-1&amp;h=401628547&amp;u=http%3A%2F%2Fwww.sec.gov%2F&amp;a=www.sec.gov\" rel=\"nofollow noopener\" target=\"_blank\"><i>www.sec.gov</i></a><i>, </i><a href=\"https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4625130-1&amp;h=923439797&amp;u=http%3A%2F%2Fwww.jnj.com%2F&amp;a=www.jnj.com\" rel=\"nofollow noopener\" target=\"_blank\"><i>www.jnj.com</i></a> <i>or on request from Johnson &amp; Johnson. Johnson &amp; Johnson does not undertake to update any forward-looking statement as a result of new information or future events or developments.</i></p><p>*Professor Shahneen Sandhu, M.D., Ph.D., MBBS, FRACP has provided consulting, advisory, and speaking services to Johnson &amp; Johnson; she has not been paid for any media work.</p><p>Source: Johnson &amp; Johnson</p><div><table border=\"0\" cellpadding=\"1\" cellspacing=\"0\" class=\"prnbcc\"><tr><td class=\"prngen2\" colspan=\"1\" rowspan=\"1\"><p class=\"prnml4\"><span class=\"prnews_span\">______________________</span></p></td></tr><tr><td class=\"prngen2\" colspan=\"1\" rowspan=\"1\"><p class=\"prnml4\"><span class=\"prnews_span\"><sup>1</sup> Patel MR, et al. Safety and Efficacy of Pasritamig (PAS) + Docetaxel (DOCE) in Participants with Metastatic Castration-Resistant Prostate Cancer (mCRPC): Initial Results of a Phase 1b Study. Presented at: 2026 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium; February 26, 2026; <location idsrc=\"xmltag.org\" value=\"LU/us.ca.sanfrn\">San Francisco, California</location>.</span></p></td></tr><tr><td class=\"prngen2\" colspan=\"1\" rowspan=\"1\"><p class=\"prnml4\"><span class=\"prnews_span\"><sup>2</sup> ClinicalTrials.gov. A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC) (KLK2-comPAS). https://clinicaltrials.gov/study/NCT07164443. Accessed February 2026.</span></p></td></tr><tr><td class=\"prngen2\" colspan=\"1\" rowspan=\"1\"><p class=\"prnml4\"><span class=\"prnews_span\"><sup>3</sup> ClinicalTrials.gov. A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer (KLK2-PASenger). https://clinicaltrials.gov/study/NCT07225946. Accessed February 2026.</span></p></td></tr><tr><td class=\"prngen2\" colspan=\"1\" rowspan=\"1\"><p class=\"prnml4\"><span class=\"prnews_span\"><sup>4</sup> ClinicalTrials.gov. A Study of JNJ-78278343 in Combination With Either JNJ-63723283 (Cetrelimab), Taxane Chemotherapy, or Androgen Receptor Pathway Inhibitors for Metastatic Prostate Cancer. https://www.clinicaltrials.gov/study/NCT05818683. Accessed February 2026.</span></p></td></tr><tr><td class=\"prngen2\" colspan=\"1\" rowspan=\"1\"><p class=\"prnml4\"><span class=\"prnews_span\"><sup>5 </sup>Kushwaha PP, Gupta S. New insights for drug resistance in metastatic castration-resistant prostate cancer. Cancer Drug Resist. 2022;5(3):846-849. Published 2022 Aug 2. doi:10.20517/cdr.2022.83</span></p></td></tr><tr><td class=\"prngen2\" colspan=\"1\" rowspan=\"1\"><p class=\"prnml4\"><span class=\"prnews_span\"><sup>6 </sup>Wallace K, Landsteiner A, Bunner S, Engel-Nitz N, Luckenbaugh A. Epidemiology and mortality of metastatic castration-resistant prostate cancer (mCRPC) in a managed care population in <location idsrc=\"xmltag.org\" value=\"LC/us\">the United States</location>. J Clin Oncol. 2020;38(15_suppl):e13592. doi:10.1200/JCO.2020.38.15_suppl.e13592</span></p></td></tr><tr><td class=\"prngen2\" colspan=\"1\" rowspan=\"1\"><p class=\"prnml4\"><span class=\"prnews_span\"><sup>7</sup> Wallace KL, Landsteiner A, Bunner SH, Engel-Nitz NM, Luckenbaugh AN. Increasing prevalence of metastatic castration-resistant prostate cancer in a managed care population in <location idsrc=\"xmltag.org\" value=\"LC/us\">the United States</location>. Cancer Causes Control. 2021;32(12):1365-1374. doi:10.1007/s10552-021-01484-4</span></p></td></tr><tr><td class=\"prngen2\" colspan=\"1\" rowspan=\"1\"><p class=\"prnml4\"><span class=\"prnews_span\"><sup>8 </sup>Kawahara T, Saigusa Y, Yoneyama S, et al. Development and validation of a survival nomogram and calculator for male patients with metastatic castration-resistant prostate cancer treated with abiraterone acetate and/or enzalutamide. BMC Cancer. 2023;23:214. doi:10.1186/s12885-023-10700-0</span></p></td></tr></table></div><p> </p><div><table border=\"0\" cellpadding=\"1\" cellspacing=\"0\" class=\"prnbcc\"><tr><td class=\"prngen3\" colspan=\"1\" rowspan=\"1\"><p class=\"prnml4\"><span class=\"prnews_span\"><b>Media contact:</b><br/>Oncology Media Relations</span></p><p class=\"prnml4\"><span class=\"prnews_span\"><a class=\"prnews_a\" href=\"mailto:oncology_media_relations@its.jnj.com\" rel=\"nofollow noopener\" target=\"_blank\">oncology_media_relations@its.jnj.com</a> </span></p></td><td class=\"prngen3\" colspan=\"1\" rowspan=\"1\"><p class=\"prnml4\"><span class=\"prnews_span\"><b>Investor contact:<br/></b>Jessica Margevich<br/><a class=\"prnews_a\" href=\"mailto:investor-relations@its.jnj.com\" rel=\"nofollow noopener\" target=\"_blank\">investor-relations@its.jnj.com</a></span></p></td></tr><tr><td class=\"prngen3\" colspan=\"1\" rowspan=\"1\"><br/></td><td class=\"prngen3\" colspan=\"1\" rowspan=\"1\"><br/></td></tr><tr><td class=\"prngen3\" colspan=\"1\" rowspan=\"1\"><br/></td><td class=\"prngen3\" colspan=\"1\" rowspan=\"1\"><p class=\"prnml4\"><span class=\"prnews_span\"><b><location idsrc=\"xmltag.org\" value=\"LC/us\">U.S.</location> Medical Inquiries</b></span></p></td></tr><tr><td class=\"prngen3\" colspan=\"1\" rowspan=\"1\"><br/></td><td class=\"prngen3\" colspan=\"1\" rowspan=\"1\"><p class=\"prnml4\"><span class=\"prnews_span\">+1 800 526-7736</span></p></td></tr></table></div><p>SOURCE Johnson &amp; Johnson</p></div></article>",
            "link": "https://www.stocktitan.net/news/JNJ/early-study-results-from-johnson-johnson-show-promising-antitumor-vfra4qqtf3lj.html",
            "author": "stocktitan",
            "pub_date": "Thu, 26 Feb 2026 19:30:00 GMT",
            "source": "stocktitan",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "DATATRAK Standalone eConsent Accelerates Clinical Trials | DTRK Stock News",
            "description": "<article class=\"article\"><p><i><strong>eConsent solution deploys in under four weeks, integrates with any EDC, and delivers affordable, patient‑centric digital consent</strong></i></p><p><strong id=\"dateline\">AUSTIN, TX / <a href=\"https://www.accessnewswire.com/\" rel=\"nofollow noopener\">ACCESS Newswire</a> / February 26, 2026 / </strong>DATATRAK International, Inc.'s<strong> (OTC:<a class=\"symbol-link\" href=\"/overview/DTRK/\" title=\"View DTRK stock overview\">DTRK</a>)</strong> DATATRAK Powered by Fountayn unified eClinical, eSource, and decentralized clinical trial (DCT) platform, announces the release of its standalone eConsent solution designed to help sponsors, CROs, and sites modernize informed consent while reducing startup timelines and technology costs. The new eConsent offering can be deployed in under four weeks and is available as a lightweight, cost‑effective module or as a fully integrated component of the DATATRAK Powered by Fountayn EDC and DCT ecosystem.</p><p>Unlike many eConsent tools that are bundled only within large, expensive ePRO or DCT packages, DATATRAK's standalone eConsent delivers flexible pricing so study teams can implement digital informed consent without paying for an entire ePRO system they do not need. Reasonable, study‑level pricing makes eConsent accessible for a broader range of trials and budgets, including early‑phase, single‑site, and investigator‑initiated studies.</p><p>\"Study teams want the benefits of modern eConsent-faster startup, better participant understanding, and cleaner documentation-without lengthy implementations or bloated platform costs,\" said Alex Tabatabai, CEO, DATATRAK. \"Our standalone eConsent is purpose‑built to launch quickly, fit into existing study infrastructure, and scale seamlessly when sponsors are ready to expand into DATATRAK EDC, ePRO, RTSM, CTMS, or full decentralized clinical trials.\"</p><p><strong>Fast Startup, IND‑Ready Timelines</strong></p><p>The DATATRAK eConsent solution is designed for implementation timelines of under four weeks, allowing study teams to go live in time for IND or ethics approval and first‑patient‑in milestones. Configuration is supported by reusable templates and best‑practice workflows that help streamline approvals and site activation.</p><p><strong>Standalone eConsent with Enterprise‑Grade Integration</strong></p><p>The eConsent module can be used as a standalone utility and integrated with third‑party infrastructure, including external EDC, RTSM, CTMS, and eTMF systems, or deployed as a native component of DATATRAK EDC. When used with DATATRAK EDC, consent data and enrollment status are seamlessly connected to subject records, randomization, and visit schedules, enabling true end‑to‑end digital trial execution on a single platform.</p><p><strong>Key Capabilities Include:</strong></p><p>1. Standalone eConsent that integrates with third‑party clinical trial systems or EDC<br/>2. Seamless integration with the consent and enrollment workflow in EDC<br/>3. Support for remote and decentralized clinical trials with patient access from any device<br/>4. Designed for protocol amendments and regulatory workflows</p><p>DATATRAK's eConsent simplifies managing protocol amendments and re‑consent, a common pain point for sponsors and sites. Study teams can easily trigger and track re‑consent when protocol changes occur, ensuring every participant is on the correct version and that audit trails remain inspection‑ready.</p><p>The system also supports tracking and managing supporting documents such as witness statements, translations, and supplemental information, helping maintain complete, compliant records across sites and regions.</p><p><strong>Flexible Patient Engagement and Enrollment Options</strong></p><p>To support both site‑based and remote enrollment, the eConsent solution enables sites to invite participants using multiple methods: email links, QR codes patients can scan on their own device, or direct registration by the physician or site staff. Sites can also schedule consent visits prior to trial enrollment, helping ensure participants have adequate time to review materials, ask questions, and complete consent in a controlled, compliant workflow.</p><p>When combined with DATATRAK's EDC, ePRO, and eSource capabilities, sponsors can extend the same patient‑centric digital experience beyond consent to ongoing data collection and engagement throughout the study.</p><p><strong>About DATATRAK</strong></p><p>DATATRAK Powered by Fountayn is transforming healthcare and life sciences through technological innovations by providing a unified, cloud based eClinical and decentralized clinical trial platform that brings together EDC, eSource, ePRO/eCOA, eConsent, RTSM, RBM, Adjudication, Imaging, Safety, Global Oversight and Enterprise Workflow Management, CTMS, eTMF, and DCT tools in a single, configurable environment. With global access from any device and a single‑source data model, DATATRAK helps sponsors, CROs, and sites accelerate study timelines, improve data quality, and reduce operational burden across all phases of clinical research. DATATRAK complies with the highest Quality Assurance standards that are 21 CFR Part 11, GDPR, GCP, HIPAA, and CDISC compliant that are fully validated by our experienced team of software quality engineers. DATATRAK's cloud-based platform is trusted in 83 countries, 6 continents, for over 10,000 clinical trials. DATATRAK is based in Austin, Texas and has team members and data hosting infrastructure in its key service regions of the United States, Europe, and Japan. For more information, visit www.fountayn.com or www.datatrak.com.</p><p><strong>Contact: </strong><a href=\"mailto:sales@fountayn.com\" rel=\"nofollow noopener\">sales@fountayn.com</a></p><p><strong>SOURCE: </strong>Datatrak International</p><br/><br/>View the original <a href=\"https://www.accessnewswire.com/newsroom/en/computers-technology-and-internet/datatrak-standalone-econsent-accelerates-clinical-trials-1141923\" rel=\"nofollow noopener\">press release</a> on ACCESS Newswire<br/><br/><img height=\"0\" loading=\"lazy\" src=\"https://app.accessnewswire.com/img.ashx?id=1141923\" width=\"0\"/></article>",
            "link": "https://www.stocktitan.net/news/DTRK/datatrak-standalone-e-consent-accelerates-clinical-0b2tvt448p1v.html",
            "author": "stocktitan",
            "pub_date": "Thu, 26 Feb 2026 17:45:00 GMT",
            "source": "stocktitan",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "PatentVest Releases New Report on The Oral Small-Molecule GLP-1 Patent Race | MDBH Stock News",
            "description": "<article class=\"article\"><p><strong>Analysis of 1,200+ patent documents reveal which programs are building durable exclusivity, and which may not be</strong></p><p>Dallas, TX, Feb.  26, 2026  (GLOBE NEWSWIRE) -- PatentVest, the first fully integrated IP intelligence and strategy firm, has released its latest <i>PatentVest Pulse</i> report, <b><i>“The Oral Small-Molecule GLP-1 Race: Beyond Orforglipron.”</i></b></p> <p>As injectable GLP-1 drugs built a <money>$71 billion</money> market while reaching less than <percent>5%</percent> of eligible patients, fifty oral small-molecule programs are now racing to unlock the remaining <percent>95%</percent>. Clinical efficacy across leading programs is converging in the 12–<percent>16%</percent> weight-loss range.</p> <p>In this increasingly competitive field, long-term differentiation depends not only on clinical performance but also on the strength and defensibility of each program’s patent portfolio.</p> <p>The report reviews more than 1,200 patent documents across 26 clinical-stage programs, mapping composition-of-matter claims, Markush scope, formulation layers, and method-of-use protection. The findings reveal dramatic disparities in patent depth between programs at similar development stages.</p> <p>More than <money>$47 billion</money> in GLP-1-related deal value has been committed since 2023, yet most oral programs remain unpartnered. With semaglutide’s patent cliff approaching in 2031 and tirzepatide’s in 2036, long-term exclusivity will determine which assets become franchises and which face early generic pressure.</p> <p>“When multiple drugs deliver similar weight-loss results, the competitive moat shifts beneath the surface,” said Javier Chamorro, Chief Operating Officer of PatentVest. “The difference between a broad genus claim and a narrow composition patent can determine who owns this market for the next twenty years.”</p> <p>This analysis maps 50 oral small-molecule GLP-1 programs worldwide, including 30 in clinical development, and evaluates the IP positioning of leading assets from Eli Lilly, Novo Nordisk, Pfizer, Roche, AstraZeneca, Gilead, Structure Therapeutics, and others.</p> <p>This is the first in a series of deep-dive analyses evaluating the structural and patent defensibility of each major program.</p> <p>PatentVest, a division of MDB Capital Holdings (Nasdaq: <a class=\"symbol-link\" href=\"/overview/MDBH/\" title=\"View MDBH stock overview\">MDBH</a>), is the first integrated IP intelligence, strategy, and law firm designed to help visionary companies become technology leaders. Powered by a proprietary global IP database and a rigorous diligence methodology, PatentVest delivers actionable intelligence that reveals the structural advantages hidden beneath technology markets.</p> <p>Read the full report here: <a href=\"https://www.globenewswire.com/Tracker?data=bUtKpFFbuLAB9OQoy6Xlg5jGoBNb8E-f1x_ArqiCiSeVjVCbTKMtI_P9D5lHvKs3Gvb4xJd0ymWdCvekizgeGJ1Kx2Fwd-Tz2SOLj12rJcRg6l0V9TwHUUW7M3IQUvMu20do0WyXoQ_768GDCIupLaKrzDNKjrAgqryg7BA_scp0upsKB6Yl6gmKL9Dpvuq2WDJohMncoMn2NOh1NUXrJyRvt2FdSH5JAktrHHeMLNJDiNzHfoa0tPhbj6vBijm1z3wkYiXR3odWpiK7L3upOoJbexrnMWpS7pkPxbuIUL-Piw4TD0R-TIwtqHHxeKLRX1Qk0uzspDq5Q1in27ZbP_w0T_-dor5lJkNjSJx3pN3LHF-fVFIgVmfUsgOMrm-T\" rel=\"nofollow noopener\" target=\"_blank\">https://insights.patentvest.com/https/www.patentvest.com/patentvest-pulse/the-oral-small-molecule-glp-1-race-beyond-orforglipron</a>.</p> <p>For more information or inquiries, please contact <a href=\"https://www.globenewswire.com/Tracker?data=ZsuQdAurh_0O0ebql8-zusf1Lk-YRwsVUdS4lC8VfcIeziRjf0E52XuKhDVKOBzqMIgyyyT2tzjAaLZGUnd6vSocU_6vNXeCqgqdr29Hoirmn1ssGZ4rxN0C4XyqMxNgRiYRcLfFaa1SAPOtahz9DMQiRLMWhI0430S_GBsbjhIrAOL7N5O3hVuHWc9yvc4dFYt8xSZ8X7DoiQw4K5a3HQ-WBTGO1IAvPdmQg6u9wL-3EI1ycGbjkwoHLckkMg88lQEEmXNb7Y5jHIZPo4HHRTAi-lxOBzWaoHN9arJt3LBSbR5pcj034feY0pt5lbFxYoDzME7M7FB-V3UM7rNuPGDOQS3vlsB63YWM50DujTsU3D_o7M2DRjuftwlXGQYzDTdQZwW7c3yDVa1bRC4dh6FnZSw2TjKCGiCM7iEYD80cY26FXKlzD8TcHESDBLG71d6LtmMGgnXOQDkJsB5Dz2J75lVbhD2o8f2NpoN-OjfH1R5YUJP41xKEbZpoDl2y\" rel=\"nofollow noopener\" target=\"_blank\">info@patentvest.com</a>.</p> <img alt=\"\" class=\"__GNW8366DE3E__IMG\" loading=\"lazy\" src=\"https://www.globenewswire.com/newsroom/ti?nf=OTY2MjMzMSM3NDU3ODg5IzUwMDEyNDY2Ng==\"/> <br/><img alt=\"\" loading=\"lazy\" referrerpolicy=\"no-referrer-when-downgrade\" src=\"https://ml.globenewswire.com/media/ZDFkNzllMGQtMjMwZC00ZWU1LTgxZTgtYmJmY2NlNDA5NzRmLTUwMDEyNDY2Ni0yMDI2LTAyLTI2LWVu/tiny/PatentVest-Inc-.png\"/></article>",
            "link": "https://www.stocktitan.net/news/MDBH/patent-vest-releases-new-report-on-the-oral-small-molecule-glp-1-k3xwdq4kiid3.html",
            "author": "stocktitan",
            "pub_date": "Thu, 26 Feb 2026 18:35:00 GMT",
            "source": "stocktitan",
            "kind": 1,
            "language": "en"
        }
    ]
}